<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Transl Int Med</journal-id><journal-id journal-id-type="iso-abbrev">J Transl Int Med</journal-id><journal-id journal-id-type="publisher-id">jtim</journal-id><journal-id journal-id-type="doi">jtim</journal-id><journal-title-group><journal-title>Journal of Translational Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">2450-131X</issn><issn pub-type="epub">2224-4018</issn><publisher><publisher-name>De Gruyter</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC10732577</article-id><article-id pub-id-type="publisher-id">jtim-2023-0116</article-id><article-id pub-id-type="doi">10.2478/jtim-2023-0116</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Impact of gut microbiota and associated mechanisms on postprandial glucose levels in patients with diabetes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Feng</surname><given-names>Xinyuan</given-names></name><xref rid="j_jtim-2023-0116_aff_001" ref-type="aff"/><xref rid="j_jtim-2023-0116_aff_002" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Deng</surname><given-names>Mingqun</given-names></name><xref rid="j_jtim-2023-0116_aff_001" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Lina</given-names></name><xref rid="j_jtim-2023-0116_aff_001" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Pan</surname><given-names>Qi</given-names></name><email xlink:href="mailto:panqi621@126.com">panqi621@126.com</email><xref rid="j_jtim-2023-0116_aff_001" ref-type="aff"/><xref rid="j_jtim-2023-0116_aff_002" ref-type="aff"/></contrib><aff id="j_jtim-2023-0116_aff_001"><institution>Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine</institution>, <city>Beijing</city>
<postal-code>100730</postal-code> ,<country country="CN">China</country></aff><aff id="j_jtim-2023-0116_aff_002"><institution>Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences</institution>, <city>Beijing</city>
<postal-code>100730</postal-code>, <country country="CN">China</country></aff></contrib-group><author-notes><corresp>Chinese Academy of Medical Sciences, Beijing 100050, China.</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>20</day><month>12</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2023</year></pub-date><volume>11</volume><issue>4</issue><fpage>363</fpage><lpage>371</lpage><permissions><copyright-statement>&#x000a9; 2023 Xinyuan Feng, Mingqun Deng, Lina Zhang, Qi Pan, published by De Gruyter on behalf of Scholar Media Publishing</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Xinyuan Feng, Mingqun Deng, Lina Zhang, Qi Pan, published by De Gruyter on behalf of Scholar Media Publishing</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under the Creative Commons Attribution 4.0 International License.</license-p></license></permissions><abstract><title>Abstract</title><p>Diabetes and its complications are serious medical and global burdens, often manifesting as postprandial hyperglycemia. In recent years, considerable research attention has focused on relationships between the gut microbiota and circulating postprandial glucose (PPG). Different population studies have suggested that PPG is closely related to the gut microbiota which may impact PPG via short-chain fatty acids (SCFAs), bile acids (BAs) and trimethylamine N-oxide (TMAO). Studies now show that gut microbiota models can predict PPG, with individualized nutrition intervention strategies used to regulate gut microbiota and improve glucose metabolism to facilitate the precision treatment of diabetes. However, few studies have been conducted in patients with diabetes. Therefore, little is known about the relationships between the gut microbiota and PPG in this cohort. Thus, more research is required to identify key gut microbiota and associated metabolites and pathways impacting PPG to provide potential therapeutic targets for PPG.</p></abstract><kwd-group><title>Key words</title><kwd>gut microbiota</kwd><kwd>postprandial glucose</kwd><kwd>precision medicine</kwd><kwd>short-chain fatty acids</kwd><kwd>bile acids</kwd><kwd>trimethylamine N-oxide</kwd></kwd-group><funding-group><funding-statement>
This project was supported by the National High Level Hospital Clinical Research Funding (BJ-2022-145) and CAMS Innovation Fund for Medical Sciences (2021-I2M-1-050).
</funding-statement></funding-group><counts><page-count count="9"/></counts></article-meta></front><body><sec id="j_jtim-2023-0116_s_001"><title>Introduction</title><p>Diabetes is one of the most common chronic non-communicable diseases which threatens global human health.<sup>[<xref rid="j_jtim-2023-0116_ref_001" ref-type="bibr">1</xref>, <xref rid="j_jtim-2023-0116_ref_002" ref-type="bibr">2</xref>]</sup> The International Diabetes Federation (10<sup>th</sup> Diabetes Atlas, 2021) reports that global disease prevalence, between the ages of 20 to 79 years, is estimated to be 10.5% (536.6 million adults),<sup>[<xref rid="j_jtim-2023-0116_ref_003" ref-type="bibr">3</xref>]</sup> with disease-related health expenditure is estimated at 966 billion dollars and is expected to reach 10.54 trillion dollars by 2045.<sup>[<xref rid="j_jtim-2023-0116_ref_004" ref-type="bibr">4</xref>]</sup> Diabetic nephropathy, diabetic retinopathy, cardiovascular events and other diabetes-related complications seriously affect the quality of life of patients, increasing the hospitalization rate and mortality of patients.<sup>[<xref rid="j_jtim-2023-0116_ref_005" ref-type="bibr">5</xref>, <xref rid="j_jtim-2023-0116_ref_006" ref-type="bibr">6</xref>, <xref rid="j_jtim-2023-0116_ref_007" ref-type="bibr">7</xref>, <xref rid="j_jtim-2023-0116_ref_008" ref-type="bibr">8</xref>, <xref rid="j_jtim-2023-0116_ref_009" ref-type="bibr">9</xref>, <xref rid="j_jtim-2023-0116_ref_010" ref-type="bibr">10</xref>, <xref rid="j_jtim-2023-0116_ref_011" ref-type="bibr">11</xref>]</sup> In China, approximately 33% of diabetic outpatients achieve blood glucose targets.<sup>[<xref rid="j_jtim-2023-0116_ref_012" ref-type="bibr">12</xref>]</sup> Blood glucose fluctuation, especially postprandial hyperglycemia, is closely related to diabetes complications.<sup>[<xref rid="j_jtim-2023-0116_ref_013" ref-type="bibr">13</xref>]</sup> Glycemic control was assessed using the hemoglobin A1c (HbA1c) level.<sup>[<xref rid="j_jtim-2023-0116_ref_014" ref-type="bibr">14</xref>]</sup> The system evaluation showed that a decrease in postprandial glucose (PPG) accounted for nearly twice as much as fasting plasma glucose (FPG) for the decreases in HbA1c.<sup>[<xref rid="j_jtim-2023-0116_ref_015" ref-type="bibr">15</xref>]</sup> So PPG had a better correlation with HbA1c than FPG. The American Diabetes Association Guidelines 2021 suggests that PPG monitoring should be conducted in patients with diabetes who failed to reach satisfactory HbA1c levels but obtained target fasting blood glucose, and PPG levels should be maintained below 10.0 mmol/L to reduce HbA1c.<sup>[<xref rid="j_jtim-2023-0116_ref_016" ref-type="bibr">16</xref>]</sup> Gastric emptying, intestinal proinsulin system, and preprandial blood glucose levels affect postprandial blood glucose levels. In recent years, more studies have reported that the gut microbiota may exert important actions on blood glucose levels, in addition to the effects of islet functions, diets, exercise, and other factors.<sup>[<xref rid="j_jtim-2023-0116_ref_017" ref-type="bibr">17</xref>,<xref rid="j_jtim-2023-0116_ref_018" ref-type="bibr">18</xref>]</sup> Studies investigating relationships between diabetes and gut microbiota have successfully shown that gut microbiota composition and abundance are related to fasting blood glucose or HbA1c levels, but few studies have focused on relationships between PPG and the gut microbiota.<sup>[<xref rid="j_jtim-2023-0116_ref_019" ref-type="bibr">19</xref>, <xref rid="j_jtim-2023-0116_ref_020" ref-type="bibr">20</xref>, <xref rid="j_jtim-2023-0116_ref_021" ref-type="bibr">21</xref>]</sup> In this review, we address this issue and examine associated underlying mechanisms.</p></sec><sec id="j_jtim-2023-0116_s_002"><title>Gut microbiota overview</title><p>As the second gene bank of human beings,<sup>[<xref rid="j_jtim-2023-0116_ref_022" ref-type="bibr">22</xref>]</sup> the number of gut microbiota is 10 times the total number of human cells, and the number of genes carried by them is more than 100 times their own. At the same time, as the microbial organ of the host, it is closely related to various metabolic pathways.<sup>[<xref rid="j_jtim-2023-0116_ref_023" ref-type="bibr">23</xref>,<xref rid="j_jtim-2023-0116_ref_024" ref-type="bibr">24</xref>]</sup> Gut microbiota is established during infancy and develops to maturity across the first 2 years of life. Their stability decreases in one&#x02019;s old age under the combined influence of genetic and environmental factors. <sup>[<xref rid="j_jtim-2023-0116_ref_025" ref-type="bibr">25</xref>]</sup> Gut microbiota can be classified by phylum, class, order, family, genus, and species, and mainly includes <italic toggle="yes">Firmicutes</italic> (<italic toggle="yes">Lactobacillus, Clostridium, Ruminococcus, etc.</italic>), <italic toggle="yes">Bacteroidetes</italic> (<italic toggle="yes">Bacteroides, Prevotella, etc.), Proteobacteria (Escherichia coli, etc.</italic>), and <italic toggle="yes">Actinobacteria</italic> (<italic toggle="yes">Bifidobacteria, etc.</italic>). Firmicutes contain the greatest number of genera, comprising more than 200 genera.<sup>[<xref rid="j_jtim-2023-0116_ref_026" ref-type="bibr">26</xref>]</sup> Regarded as a unique host microbial organ, intestinal microorganisms are closely associated with different metabolic pathways. Gut microbiota breaks down undigested plant polysaccharides, proteins or amino acids by encoding active enzymes of carbohydrates and protein,<sup>[<xref rid="j_jtim-2023-0116_ref_027" ref-type="bibr">27</xref>]</sup> and those resultant metabolites could exert a biological activity and affect the metabolism of body.<sup>[<xref rid="j_jtim-2023-0116_ref_028" ref-type="bibr">28</xref>]</sup></p></sec><sec id="j_jtim-2023-0116_s_003"><title>PPG and its clinical significance</title><p>PPG is one of the main reasons for increased HbA1c levels.<sup>[<xref rid="j_jtim-2023-0116_ref_029" ref-type="bibr">29</xref>, <xref rid="j_jtim-2023-0116_ref_030" ref-type="bibr">30</xref>]</sup> High PPG is closely related to the occurrence and development of chronic diabetic complications.<sup>[<xref rid="j_jtim-2023-0116_ref_031" ref-type="bibr">31</xref>, <xref rid="j_jtim-2023-0116_ref_032" ref-type="bibr">32</xref>, <xref rid="j_jtim-2023-0116_ref_033" ref-type="bibr">33</xref>]</sup> Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with type 2 diabetes mellitus (HEART2D) study compared the effects of different blood glucose control strategies on cardiovascular endpoints in 1115 type 2 diabetes (T2D) patients after acute myocardial infarction. The study showed that in patients older than 65.7 years, there is no significant differences in baseline characteristics including HbA1c, diabetic therapies, prior cardiovascular disease history, or other clinically relevant measures between different study arms.<sup>[<xref rid="j_jtim-2023-0116_ref_034" ref-type="bibr">34</xref>]</sup> The PPG control group recorded a significantly less time to the first cardiovascular event, and a significantly lower proportion of patients experienced a first cardiovascular event when compared with the fasting blood glucose control group (<italic toggle="yes">n</italic> = 56 [29.6%] <italic toggle="yes">vs</italic>. <italic toggle="yes">n</italic> = 85 [40.5%]; hazard ratio = 0.69 [95% confidence interval (CI): 0.49 to 0.96]; <italic toggle="yes">P</italic> = 0.029). Controlling PPG is important for promoting HbA1c levels and preventing microvascular and macrovascular diseases and heart events in diabetes.<sup>[<xref rid="j_jtim-2023-0116_ref_035" ref-type="bibr">35</xref>]</sup> After eating the same foods, PPG in an Asian population was higher when compared with Caucasians, and was putatively related to chewing habits, basic oral hygiene, high amylase activity,<sup>[<xref rid="j_jtim-2023-0116_ref_036" ref-type="bibr">36</xref>]</sup> oral physiological, anatomical parameters and other factors in these populations.<sup>[<xref rid="j_jtim-2023-0116_ref_037" ref-type="bibr">37</xref>]</sup> For these populations, PPG appeared to contribute to HbA1c. Therefore, more attention must be paid to PPG in this group.</p></sec><sec id="j_jtim-2023-0116_s_004"><title>Relationships between gut microbiota and PPG</title><sec id="j_jtim-2023-0116_s_004_s_001"><title>In vitro research progress on gut microbiota and glucose lipid metabolism</title><p>The molecular mechanisms by which gut microbiota affects host metabolic balance mainly include the following two ways: (1) the role of gut microbiota itself; (2) the effects mediated by metabolites of gut microbiota.<sup>[<xref rid="j_jtim-2023-0116_ref_038" ref-type="bibr">38</xref>,<xref rid="j_jtim-2023-0116_ref_039" ref-type="bibr">39</xref>]</sup> Gut microbiota can have a direct impact on the host by disrupting the integrity of the intestinal mucosal barrier, allowing molecules such as lipopolysaccharides (LPS) to enter the host cycle. LPS of <italic toggle="yes">Akkermansia muciniphila</italic> can specifically activate the expression of Toll-like receptors 2 (TLR2).<sup>[<xref rid="j_jtim-2023-0116_ref_040" ref-type="bibr">40</xref>]</sup> A His-tagged Amuc_1100 produced in <italic toggle="yes">E. coli</italic> (hereafter called Amuc_1100*) could similarly signal TLR2-expressing cells to <italic toggle="yes">A. muciniphila</italic>. Plover <italic toggle="yes">et al</italic>. <sup>[<xref rid="j_jtim-2023-0116_ref_041" ref-type="bibr">41</xref>]</sup>&#x02019;s research has shown that Amuc_ 1100 * improves the metabolic syndrome in obese and diabetic mice through TLR2 signaling. Compared with normal-fed mice, untreated high-fat fed mice exhibited lower phosphorylation of the protein kinase B (PKB/Akt) pathway, while mice fed with Amuc_1100 * treatment offset this impact and improved insulin sensitivity. In addition, gut microbiota can also have indirect effects through its metabolites, such as the production of short-chain fatty acids (SCFAs), bile acids (BAs), trimethylamine N-oxide (TMAO), <italic toggle="yes">etc</italic>., which affect the metabolism (<xref rid="j_jtim-2023-0116_tab_001" ref-type="table">Table 1</xref>).</p><table-wrap position="float" id="j_jtim-2023-0116_tab_001"><label>Table 1</label><caption><p>The mechanism of the effect of gut microbiota metabolites on postprandial blood glucose</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Gut microbiota metabolites</th><th align="left" rowspan="1" colspan="1">Related signaling pathways/signaling molecules/key enzymes</th><th align="left" rowspan="1" colspan="1">Microbiota</th><th align="left" rowspan="1" colspan="1">Mechanism</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">SCFA (butyrate, formic, acetic, and propionic acids)</td><td align="left" rowspan="1" colspan="1">FFAR2 FFAR3</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Bacteroidetes Firmicutes Lachnospiraceae Ruminococcus</italic>
</td><td align="left" rowspan="1" colspan="1">SCFA binds to specific transmembrane receptors FFAR2 and FFAR3 stimulates GLP-1 and PYY secretion, inhibits appetite, and reduces PPG.</td></tr><tr><td align="left" rowspan="1" colspan="1">BA</td><td align="left" rowspan="1" colspan="1">FXR TGR5</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Clostridium Bacteroides Lactobacillus Bifidobacterium</italic>
</td><td align="left" rowspan="1" colspan="1">BA regulates PPG through signals from multiple parts of the body. Liver BA-FXR promotes glycogen synthesis; Intestinal BA-TGR5 promotes GLP-1 expression and secretion, while BA-FXR inhibits GLP-1 production; BA-TGR5 mediates satiety in the brain and increases energy consumption in skeletal muscle and brown adipose tissue; Pancreatic islet &#x003b2; BA-TGR5 and BA-FXR in cells induce insulin production.</td></tr><tr><td align="left" rowspan="1" colspan="1">TMAO, TMA</td><td align="left" rowspan="1" colspan="1">FMO3 PKA IGF-2 PI3K/Akt</td><td align="left" rowspan="1" colspan="1">
<italic toggle="yes">Bacteroidetes, Firmicutes</italic>
</td><td align="left" rowspan="1" colspan="1">The levels of TMAO and TMA increase after meals, which affect the phosphorylation process of PKA and IGF-2, and block the PI3K/Akt insulin signaling pathway to increase PPG.</td></tr></tbody></table><table-wrap-foot><fn id="j_jtim-2023-0116_tfn_101"><p>SCFA: short-chain fatty acid, FFAR2: free fatty acid receptor 2, FFAR3: free fatty acid receptor 3, BA: bile acid, FXR: farnesoid X receptor, TGR5: Takeda G protein receptor 5, TMAO: trimethylamine oxide, TMA: trimethylamine, FMO3: Flavin containing monooxygenase 3, PI3K/Akt: phosphatidylinositol 3-kinase/protein kinase B, IGF-2: insulin-like growth factor 2, PKA: protein kinase A, GLP-1: glucagon-like peptide 1, PPG: postprandial glucose.</p></fn></table-wrap-foot></table-wrap></sec><sec id="j_jtim-2023-0116_s_004_s_002"><title>PPG in different populations</title><p>Postprandial glucose responses (PPGR) reflect increased areas under blood glucose response curves within 2 hours after eating.<sup>[<xref rid="j_jtim-2023-0116_ref_042" ref-type="bibr">42</xref>]</sup> Despite eating the same food, the PPGR of different individuals was significantly different, and the level of PPG was also different. In addition to food characteristics (<italic toggle="yes">e.g.</italic> carbohydrate content) and genetic factors, PPGR may be affected by intestinal microbiome differences in different individuals.<sup>[<xref rid="j_jtim-2023-0116_ref_043" ref-type="bibr">43</xref>,<xref rid="j_jtim-2023-0116_ref_044" ref-type="bibr">44</xref>]</sup></p></sec><sec id="j_jtim-2023-0116_s_004_s_003"><title>PPG in non-diabetic individuals</title><p>In normal populations, PPG levels may be somewhat predicted by combined information such as diet, body composition, and gut microbiota. Zeevi <italic toggle="yes">et al</italic>.<sup>[<xref rid="j_jtim-2023-0116_ref_045" ref-type="bibr">45</xref>]</sup> integrated data from 800 non-diabetic subjects and generated a personalized PPGR prediction model, and showed that <italic toggle="yes">Proteobacteria</italic> and <italic toggle="yes">Enterobacter</italic> were positively associated with PPGR in standardized diets. Using a standardized PPGR prediction model in healthy Danish adults, it was suggested that intestinal metagenomic species abundance, specifically, <italic toggle="yes">Clostridia MGS.hg0341</italic> and <italic toggle="yes">Bifidobacteria</italic> were negatively associated with PPG.<sup>[<xref rid="j_jtim-2023-0116_ref_046" ref-type="bibr">46</xref>]</sup> Nolte <italic toggle="yes">et al</italic>. reported similar findings that <italic toggle="yes">Faecalibacterium prausnitzii</italic> was negatively associated with PPG.<sup>[<xref rid="j_jtim-2023-0116_ref_047" ref-type="bibr">47</xref>]</sup> In the elderly, certain correlations exist between intestinal bacteria and PPG; research in elderly healthy individuals (&#x0003e; 65 years old) reported significant correlations between gut bacteria and peak glucose levels after dinner and the 4-hour area under the curve (AUC) period after dinner.<sup>[<xref rid="j_jtim-2023-0116_ref_048" ref-type="bibr">48</xref>]</sup>
<italic toggle="yes">Bacteroidetes</italic>, <italic toggle="yes">Blautia</italic>, and <italic toggle="yes">Bilophila</italic> are positive, while <italic toggle="yes">Ruminococcus</italic> and <italic toggle="yes">Holdmannia</italic> are negatively associated with PPG.<sup>[<xref rid="j_jtim-2023-0116_ref_049" ref-type="bibr">49</xref>]</sup></p></sec><sec id="j_jtim-2023-0116_s_004_s_004"><title>Relationships between gut microbiota and diabetic PPG</title><p>Intestinal microbial composition in patients with diabetes is distinct when compared with healthy individuals. A systematic review of 25 studies comprising 2209 type 1 diabetes (T1D) and T2D patients reported no significant changes in the number of gut microbiota in this population, but <italic toggle="yes">Bacteroides</italic>, <italic toggle="yes">Bifidobacterium</italic>, and <italic toggle="yes">Clostridium</italic> abundance had decreased and were negatively associated with blood sugar levels.<sup>[<xref rid="j_jtim-2023-0116_ref_050" ref-type="bibr">50</xref>]</sup></p><p>For patients with T1D, decreased <italic toggle="yes">Firmicutes/Bacteroides</italic> ratios may be related to T1D incidences and increased HbA1c levels.<sup>[<xref rid="j_jtim-2023-0116_ref_051" ref-type="bibr">51</xref>]</sup> Gut microbiota diversity in T1D patients is associated with HbA1c levels.<sup>[<xref rid="j_jtim-2023-0116_ref_052" ref-type="bibr">52</xref>]</sup> Research has suggested that gut microbiota diversity in adult T1D patients who are not newly diagnosed and whose mean/median HbA1c levels are less than 8% are similar to those of normal individuals, but when HbA1c levels exceed 8%, gut microbiota diversity is distinct from healthy individuals. <sup>[<xref rid="j_jtim-2023-0116_ref_053" ref-type="bibr">53</xref>]</sup> A previous T1D study reported that gut microbiota affected PPG; a prediction model incorporated gut microbiota characteristics can predict PPGR in T1D patients, except for the effects of carbohydrate content, and the proportion of carbohydrate to fat on PPG.<sup>[<xref rid="j_jtim-2023-0116_ref_054" ref-type="bibr">54</xref>,<xref rid="j_jtim-2023-0116_ref_055" ref-type="bibr">55</xref>]</sup> Shilo <italic toggle="yes">et al</italic>. enrolled 121 T1D patients, measured 6377 PPG data points, and designed a prediction model, which integrated blood glucose levels, insulin doses, dietary habits, and gut microbiota to accurately predict PPGR and provide T1D patients with optimal meal insulin doses.<sup>[<xref rid="j_jtim-2023-0116_ref_056" ref-type="bibr">56</xref>]</sup></p><p>For T2D patients, the study showed that <italic toggle="yes">Roseburia</italic> and <italic toggle="yes">Faecalibacterium</italic> abundance decreased, while <italic toggle="yes">Lactobacillus gasseri</italic>, <italic toggle="yes">Streptococcus mutans</italic>, and some <italic toggle="yes">Clostridium spp</italic>. abundance increased when compared with a healthy population.<sup>[<xref rid="j_jtim-2023-0116_ref_057" ref-type="bibr">57</xref>]</sup> Blood glucose levels in T2D patients are associated with gut microbiota abundance.<sup>[<xref rid="j_jtim-2023-0116_ref_058" ref-type="bibr">58</xref>]</sup>
<italic toggle="yes">Enterobacteria</italic> and <italic toggle="yes">Enterococci</italic> abundance is less in patients with good blood glucose control (HbA1c &#x0003c; 6.5%) when compared with patients with poor blood glucose control (HbA1c &#x02265; 6.5%), while <italic toggle="yes">Bifidobacteria</italic> and <italic toggle="yes">Bacteroidetes</italic> abundance is higher when compared with patients with poor blood glucose control.<sup>[<xref rid="j_jtim-2023-0116_ref_059" ref-type="bibr">59</xref>]</sup> Studies have shown that intestinal microbial interventions can affect PPG. In one study, 102 T2D patients were randomly divided into two groups; the control group was given basic hypoglycemic drugs and the intervention group was given hypoglycemic drugs plus triple viable <italic toggle="yes">Bifidobacterium</italic> capsules. After 8 weeks, <italic toggle="yes">Bifidobacteria</italic> and <italic toggle="yes">Lactobacilli</italic> levels increased in the intervention group when compared with the control group, and <italic toggle="yes">Enterococcus</italic> and <italic toggle="yes">coccobacillus</italic> abundance decreased. Also, mean 2-hour PPG levels in the intervention group were 1.54 mmo/L lower when compared with the control group (<italic toggle="yes">P</italic> = 0.026).<sup>[<xref rid="j_jtim-2023-0116_ref_060" ref-type="bibr">60</xref>]</sup></p></sec><sec id="j_jtim-2023-0116_s_004_s_005"><title>How the gut microbiota affects PPG</title><p>In addition to directly acting through its own LPS, gut microbiota can generate various bioactive metabolites such as short-chain fatty acids, bile acids, and trimethylamine oxide through the liver or intestines. These metabolites can serve as indirect regulatory factors, regulating host glucose metabolism and insulin signaling pathways, and affecting postprandial glucose through related metabolic pathways in different tissues and organs (<xref rid="j_jtim-2023-0116_fig_001" ref-type="fig">Figure 1</xref>).</p><fig position="float" id="j_jtim-2023-0116_fig_001" fig-type="figure"><label>Figure 1</label><caption><p>Mechanisms showing how the microbiota potentially reduce postprandial blood glucose. A. Gut microbiota mainly includes Firmicutes, Bacteroidetes, Proteobateria and Actinobacteria. B. Undigested dietary fiber generates SCFAs via microbiota fermentation in the intestine (blue arrow); BA is secreted into bile by liver cells, enters the intestine and participates in the hepatointestinal circulation (green arrow); After high-fat food is eaten, TMA is generated through gut microbiota enzymes, and TMA generates TMAO under the action of liver FMO3 (red arrow). C. Gut microbiota generates many signaling metabolites, such as SCFAs, BAs and TMAO, which participate in different metabolic pathways to ultimately affect PPG. SCFAs: short-chain fatty acids, BA: bile acid, TMA: trimethylamine, FMO3: Flavin containing monooxygenase 3, TMAO: trimethylamine oxide, PI3K/Akt: phosphatidylinositol 3-kinase/protein kinase B, FFAR2: free fatty acid receptor 2, FFAR3: free fatty acid receptor 3, TGR5: Takeda G protein receptor 5, FXR: farnesoid X receptor, GLP-1: glucagon-like peptide 1, PPG: postprandial glucose</p></caption><graphic xlink:href="j_jtim-2023-0116_fig_001" position="float"/></fig><p><bold>Role of short-chain fatty acids:</bold> Undigested dietary fiber generates SCFAs <italic toggle="yes">via</italic> bacterial fermentation in the distal ileum and colon.<sup>[<xref rid="j_jtim-2023-0116_ref_061" ref-type="bibr">61</xref>]</sup> SCFAs are organic fatty acids that contain 1&#x02013;6 carbon atoms.<sup>[<xref rid="j_jtim-2023-0116_ref_062" ref-type="bibr">62</xref>]</sup> Butyrate is the main energy source for gut epithelial cells,<sup>[<xref rid="j_jtim-2023-0116_ref_063" ref-type="bibr">63</xref>]</sup> and is closely associated with metabolism. SCFAs also include formic, acetic, and propionic acids.<sup>[<xref rid="j_jtim-2023-0116_ref_064" ref-type="bibr">64</xref>]</sup> Many bacteria produce acetic acid,<sup>[<xref rid="j_jtim-2023-0116_ref_065" ref-type="bibr">65</xref>]</sup> while <italic toggle="yes">Bacteroidetes</italic> is the dominant propionic acid producer,<sup>[<xref rid="j_jtim-2023-0116_ref_066" ref-type="bibr">66</xref>]</sup> and <italic toggle="yes">Firmicutes</italic> is the dominant butyrate producer.<sup>[<xref rid="j_jtim-2023-0116_ref_067" ref-type="bibr">67</xref>]</sup> SCFAs are implicated in carbohydrate metabolism <italic toggle="yes">via</italic> different metabolic pathways to reduce PPG levels.<sup>[<xref rid="j_jtim-2023-0116_ref_068" ref-type="bibr">68</xref>]</sup> SCFAs and their specific transmembrane receptors, including the free fatty acid receptor 2 (FFAR2) and the free fatty acid receptor 3 (FFAR3), are involved in glucose and lipid metabolism.<sup>[<xref rid="j_jtim-2023-0116_ref_069" ref-type="bibr">69</xref>]</sup> It was reported that acetic acid selectively mediated Gq/11 or Gi/o pathways <italic toggle="yes">via</italic> FFAR2 and FFAR3 to increase or decrease glucose-induced insulin secretion.<sup>[<xref rid="j_jtim-2023-0116_ref_070" ref-type="bibr">70</xref>]</sup> FFAR3 has Gi/o coupling, and FFAR2 is doubly coupled through the Gi/o and Gq families.<sup>[<xref rid="j_jtim-2023-0116_ref_071" ref-type="bibr">71</xref>]</sup> Additionally, butyrate is mainly produced by <italic toggle="yes">Lachnospiraceae</italic> and <italic toggle="yes">Ruminococcus</italic>,<sup>[<xref rid="j_jtim-2023-0116_ref_072" ref-type="bibr">72</xref>]</sup> which reduces PPG and improves insulin sensitivity <italic toggle="yes">via</italic> epigenetic regulation, mitochondrial &#x003b2;-oxidation, and &#x003b2;-cell proliferation.<sup>[<xref rid="j_jtim-2023-0116_ref_073" ref-type="bibr">73</xref>]</sup></p><p>The gut microbiota impacts PPG by producing SCFAs which stimulate glucagon-like peptide 1 (GLP-1) secretion <italic toggle="yes">via</italic> FFAR2 and FFAR3, induce glucose-dependent insulin secretion and inhibit glucagon secretion.<sup>[<xref rid="j_jtim-2023-0116_ref_074" ref-type="bibr">74</xref>]</sup> SCFAs also stimulate peptide YY secretion to inhibit the appetite and decrease PPG levels.<sup>[<xref rid="j_jtim-2023-0116_ref_075" ref-type="bibr">75</xref>]</sup> Vitale <italic toggle="yes">et al</italic>. reported that when compared with control meals, a Mediterranean diet group had significantly lower PPG and insulin responses, and that blood glucose and insulin sensitivity levels were improved after an 8-week dietary intervention.<sup>[<xref rid="j_jtim-2023-0116_ref_053" ref-type="bibr">53</xref>]</sup> Butyric acid levels in the Mediterranean diet group also increased significantly after meals (<italic toggle="yes">P</italic> = 0.019) and were directly related to insulin sensitivity (<italic toggle="yes">r</italic> = 0.397, <italic toggle="yes">P</italic> = 0.050). These metabolic changes were accompanied by significant changes in intestinal microbiota; when compared with the control group, <italic toggle="yes">Intestinimonas butyriciproducens</italic> and <italic toggle="yes">Akkermansia muciniphila</italic> abundance in the Mediterranean diet group increased.</p><p><bold>Role of bile acids:</bold> BAs are diversified amphipathic steroid molecules which promote intestinal absorption and dietary lipid transportation,<sup>[<xref rid="j_jtim-2023-0116_ref_076" ref-type="bibr">76</xref>]</sup> with concentrations dependent on biosynthesis, enterohepatic circulation, and intestinal microbiota levels.<sup>[<xref rid="j_jtim-2023-0116_ref_077" ref-type="bibr">77</xref>]</sup>
<italic toggle="yes">Clostridium</italic>, <italic toggle="yes">Bacteroides</italic>, <italic toggle="yes">Lactobacillus</italic>, <italic toggle="yes">Bifidobacterium</italic> and <italic toggle="yes">Enterococcus</italic> have been proven to be involved in the production of bile acid.<sup>[<xref rid="j_jtim-2023-0116_ref_078" ref-type="bibr">78</xref>]</sup> Recent research reported that BAs are key signal molecules in glucose, lipid, and energy metabolism as they combine with the farnesoid X receptor (FXR) and the Takeda G-protein-coupled receptor 5 (TGR5) in multiple tissues and organs to regulate GLP-1 secretion, gluconeogenesis, glycogen synthesis, inflammatory responses, and gut microbiome structures.<sup>[<xref rid="j_jtim-2023-0116_ref_079" ref-type="bibr">79</xref>, <xref rid="j_jtim-2023-0116_ref_080" ref-type="bibr">80</xref>, <xref rid="j_jtim-2023-0116_ref_081" ref-type="bibr">81</xref>, <xref rid="j_jtim-2023-0116_ref_082" ref-type="bibr">82</xref>]</sup> FXR is widely expressed in various tissues and organs such as the intestine, liver, and white adipose tissue, which can form heterodimers to inhibit the expression of the rate limiting enzyme cholesterol 7&#x003b1;-hydroxylase (CYP7A1) in BA biosynthesis, weakening cholesterol liver conversion; The expression of CYP7A1 alleviated metabolic disorders associated with obesity, including glucose intolerance, insulin resistance, and dyslipidemia.<sup>[<xref rid="j_jtim-2023-0116_ref_083" ref-type="bibr">83</xref>,<xref rid="j_jtim-2023-0116_ref_084" ref-type="bibr">84</xref>]</sup> TGR5 is a G protein-coupled receptor, which can produce cAMP through BAs, and then activate the protein kinase A (PKA) pathway.<sup>[<xref rid="j_jtim-2023-0116_ref_085" ref-type="bibr">85</xref>]</sup> In the liver, BA-FXR signal transduction inhibits gluconeogenesis and promotes glycogen synthesis by negative modulation. In intestinal cells, BA-TGR5 signaling promotes GLP-1 expression and secretion, while BA-FXR signaling inhibits GLP-1 production. In addition, BA-TGR5 signal transduction can mediate satiety in the brain, and increase energy consumption in skeletal muscle and brown adipose tissue. In the pancreas, &#x003b2; BA-TGR5 and BA-FXR signaling in cells induce insulin production.<sup>[<xref rid="j_jtim-2023-0116_ref_086" ref-type="bibr">86</xref>, <xref rid="j_jtim-2023-0116_ref_087" ref-type="bibr">87</xref>, <xref rid="j_jtim-2023-0116_ref_088" ref-type="bibr">88</xref>]</sup> BA sequestrants (BAS) or bariatric surgery can significantly eliminate blood glucose abnormalities. A meta-analysis of 2950 T2D patients from 17 studies reported that HbA1c levels in a BAS group decreased when compared with a control group (mean difference -0.55%; 95% CI: -0.64 to -0.46).<sup>[<xref rid="j_jtim-2023-0116_ref_089" ref-type="bibr">89</xref>]</sup> Bariatric surgery alters the enterohepatic BA circulation, resulting in increased plasma bile levels as well as altered BA composition.<sup>[<xref rid="j_jtim-2023-0116_ref_090" ref-type="bibr">90</xref>]</sup> Weight loss surgery, especially Roux-en-Y gastric bypass surgery, can increase circulating BA concentrations.<sup>[<xref rid="j_jtim-2023-0116_ref_091" ref-type="bibr">91</xref>]</sup> Postoperative BA concentrations are positively correlated with serum GLP-1 concentrations but negatively correlated with PPG.<sup>[<xref rid="j_jtim-2023-0116_ref_092" ref-type="bibr">92</xref>]</sup> In addition to SCFAs and BAs actions, amino acids and their metabolites, especially tryptophan and associated derivatives, can affect glucose metabolism, but research suggests that amino acid metabolic pathways may affect diabetes and fasting blood glucose levels.<sup>[<xref rid="j_jtim-2023-0116_ref_093" ref-type="bibr">93</xref>, <xref rid="j_jtim-2023-0116_ref_094" ref-type="bibr">94</xref>, <xref rid="j_jtim-2023-0116_ref_095" ref-type="bibr">95</xref>]</sup> However, few studies have investigated the effects of gut microbiota on PPG <italic toggle="yes">via</italic> amino acid pathways.<sup>[<xref rid="j_jtim-2023-0116_ref_096" ref-type="bibr">96</xref>]</sup></p><p><bold>Effect of trimethylamine oxide:</bold> Ingestion of high-fat foods can generate the primary intestinal metabolite trimethylamine (TMA) through gut microbiota enzymes such as CutC/D,<sup>[<xref rid="j_jtim-2023-0116_ref_097" ref-type="bibr">97</xref>,<xref rid="j_jtim-2023-0116_ref_098" ref-type="bibr">98</xref>]</sup> CntA/B,<sup>[<xref rid="j_jtim-2023-0116_ref_099" ref-type="bibr">99</xref>]</sup> and YeaW/X.<sup>[<xref rid="j_jtim-2023-0116_ref_100" ref-type="bibr">100</xref>]</sup> TMA is mostly produced by <italic toggle="yes">Bacteroidetes</italic> or <italic toggle="yes">Firmicutes</italic> bacteria.<sup>[<xref rid="j_jtim-2023-0116_ref_101" ref-type="bibr">101</xref>]</sup> Flavin containing monooxygenase 3 (FMO3) in the liver can promote TMA to produce TMAO.<sup>[<xref rid="j_jtim-2023-0116_ref_102" ref-type="bibr">102</xref>,<xref rid="j_jtim-2023-0116_ref_103" ref-type="bibr">103</xref>]</sup> Previous studies have found that the TMAO pathway is associated with the occurrence and development of diseases such as heart failure, chronic kidney disease, and obesity.<sup>[<xref rid="j_jtim-2023-0116_ref_104" ref-type="bibr">104</xref>,<xref rid="j_jtim-2023-0116_ref_105" ref-type="bibr">105</xref>]</sup> Research has shown that TMA and TMAO peak levels occur approximately 4 hours after a single feeding of a high-fat diet in fasted mice, indicating that TMA and TMAO are produced after meals and exhibit hormonal oscillations related to TMA source nutrient intake. Some TMA and TMAO are involved in phosphorylation processes such as PKA and insulin like growth factor 2 (IGF-2), and regulate the cascade reaction of insulin signaling.<sup>[<xref rid="j_jtim-2023-0116_ref_106" ref-type="bibr">106</xref>]</sup> Animal experiments have shown that mice fed a high-fat diet have an increase in TMAO, exacerbating impaired glucose tolerance and insulin resistance, and leading to inflammation of adipose tissue in mice fed a high-fat diet. This process may be related to block the insulin signaling pathway through the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway.<sup>[<xref rid="j_jtim-2023-0116_ref_107" ref-type="bibr">107</xref>]</sup> An 8-week dietary intervention was conducted on patients with abnormal blood glucose levels, and the results showed a decrease in TMAO levels after intervention with a purely vegetarian diet, accompanied by a decrease in postprandial blood glucose levels.<sup>[<xref rid="j_jtim-2023-0116_ref_108" ref-type="bibr">108</xref>]</sup> In summary, the gut microbiota can affect PPG through the metabolite TMAO of a high-fat diet.</p></sec><sec id="j_jtim-2023-0116_s_004_s_006"><title>Gut microbiota in PPG and its role in precision medicine</title><p>Under the combined effects of the intestinal flora and other factors, when the same foods are eaten, blood glucose levels are differentially affected in individuals.<sup>[<xref rid="j_jtim-2023-0116_ref_109" ref-type="bibr">109</xref>]</sup> The development of individualized hypoglycemic intervention strategies for different blood glucose responses may facilitate more stable blood glucose control strategies. T1D depends on insulin treatment, and appropriate insulin doses are important to control blood glucose levels in patients. The traditional method of calculating good glycemic indices to guide insulin doses is not enough to control T1D blood glucose levels.<sup>[<xref rid="j_jtim-2023-0116_ref_110" ref-type="bibr">110</xref>]</sup> Based on the tenet that the gut microbiota impacts PPG, prediction models incorporating gut microbiota are important methods for predicting PPGR and may provide personalized treatments for T1D in the future.<sup>[<xref rid="j_jtim-2023-0116_ref_111" ref-type="bibr">111</xref>]</sup> Individualized nutrition interventions can also affect the gut microbiota and improve PPG. Studies have suggested that environmental factors may have greater roles than genetics in shaping human gut microbiota composition.<sup>[<xref rid="j_jtim-2023-0116_ref_112" ref-type="bibr">112</xref>]</sup> Personalized nutrition regimens, based on the microbiota, have been used to predict and guide blood glucose levels to generate individualized diabetes prevention and treatment strategies.<sup>[<xref rid="j_jtim-2023-0116_ref_113" ref-type="bibr">113</xref>]</sup> The cohort study of Zeevi <italic toggle="yes">et al</italic>.<sup>[<xref rid="j_jtim-2023-0116_ref_045" ref-type="bibr">45</xref>]</sup> monitored the weekly blood glucose level of 800 people and measured the blood glucose response to 46898 meals. The prediction algorithm based on the above data integrates the blood parameters, eating habits, anthropometry, physical activity and intestinal microbiota measured in the queue and can accurately predict the PPGR to the real diet. In addition, they validated these predictions in an independent 100-participant cohort, the authors showed that PPG levels in the bad diet group were significantly higher when compared with the good diet group, and the bad diet group had greater glucose fluctuations evaluated by the continuous blood glucose monitoring system after 1 week. Gut microbiota analyses indicated that <italic toggle="yes">Bifidobacteria</italic> and <italic toggle="yes">Bacteroidetes</italic> abundance were higher in the healthy diet group.</p></sec></sec><sec id="j_jtim-2023-0116_s_005"><title>Conclusion</title><p>While numerous studies have shown that gut microbiota is related to PPG and can predict PPGR in non-diabetic populations, limited research focuses on how it predicts and affects PPGR in diabetic patients. More research is required in this area to identify precise interventions and reduce complication risks in diabetic patients. Gut microbiota generates many signaling metabolites, such as SCFAs, BAs, and TMAO, which participate in different metabolic pathways to ultimately affect PPG. However, the precise mechanisms underpinning their impact on PPG remain unclear. Future research must identify key gut microbiota and associated metabolites and pathways impacting PPG and provide potential therapeutic targets for improving PPG outcomes.</p></sec></body><back><fn-group><fn fn-type="other" id="j_jtim-2023-0116_fn_001"><p>
<bold>Author Contributions</bold>
</p><p>Pan Q made substantial contributions to the study concept and design and critically revised the manuscript for important intellectual content. Feng X drafted the manuscript. Deng M and Zhang L helped to improve the English of the paper. All authors have read and approved the final version to be published.</p></fn><fn fn-type="COI-statement" id="jtim-2023-0116_fn_002"><p>
<bold>Conflicts of Interest</bold>
</p><p>The authors declare no competing interest.</p></fn><fn fn-type="other" id="jtim-2023-0116_fn_003"><p>
<bold>Data Availability Statement</bold>
</p><p>No additional data is available.</p></fn></fn-group><ref-list><title>References</title><ref id="j_jtim-2023-0116_ref_001"><label>1</label><element-citation publication-type="journal"><name><surname>Cho</surname><given-names>NH</given-names></name><name><surname>Shaw</surname><given-names>JE</given-names></name><name><surname>Karuranga</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>da Rocha</surname><given-names>Fernandes JD</given-names></name><name><surname>Ohlrogge</surname><given-names>AW</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.</article-title><source>Diabetes Res Clin Pract</source><year>2018</year><volume>138</volume><fpage>271</fpage><comment>&#x02013;</comment><lpage>281</lpage><pub-id pub-id-type="pmid">29496507</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_002"><label>2</label><element-citation publication-type="journal"><article-title>Chinese Elderly Type 2 Diabetes Prevention and Treatment of Clinical Guidelines Writing Group Geriatric Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Society Geriatric Geriatric Endocrinology and Metabolism Branch of Chinese Geriatric Health Care Society Geriatric Geriatric Professional Committee of Beijing Medical Award Foundation National Clinical Medical Research Center for Geriatric Diseases (PLA General Hospital). Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)</article-title><source>Zhong hua Nei Ke Za Zhi</source><year>2022</year><volume>61</volume><fpage>12</fpage><comment>&#x02013;</comment><lpage>50</lpage></element-citation></ref><ref id="j_jtim-2023-0116_ref_003"><label>3</label><element-citation publication-type="journal"><name><surname>Saeedi</surname><given-names>P</given-names></name><name><surname>Petersohn</surname><given-names>I</given-names></name><name><surname>Salpea</surname><given-names>P</given-names></name><name><surname>Malanda</surname><given-names>B</given-names></name><name><surname>Karuranga</surname><given-names>S</given-names></name><name><surname>Unwin</surname><given-names>N</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.</article-title><source>Diabetes Res Clin Pract</source><year>2019</year><volume>157</volume><fpage>107843</fpage><pub-id pub-id-type="pmid">31518657</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_004"><label>4</label><element-citation publication-type="journal"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Saeedi</surname><given-names>P</given-names></name><name><surname>Karuranga</surname><given-names>S</given-names></name><name><surname>Pinkepank</surname><given-names>M</given-names></name><name><surname>Ogurtsova</surname><given-names>K</given-names></name><name><surname>Duncan</surname><given-names>BB</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045.</article-title><source>Diabetes Res Clin Pract</source><year>2022</year><volume>183</volume><fpage>109119</fpage><pub-id pub-id-type="pmid">34879977</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_005"><label>5</label><element-citation publication-type="journal"><name><surname>Cagnin</surname><given-names>S</given-names></name><name><surname>Brugnaro</surname><given-names>M</given-names></name><name><surname>Millino</surname><given-names>C</given-names></name><name><surname>Pacchioni</surname><given-names>B</given-names></name><name><surname>Troiano</surname><given-names>C</given-names></name><name><surname>Di</surname><given-names>Sante M</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Monoamine Oxidase-Dependent Pro-Survival Signaling in Diabetic Hearts Is Mediated by miRNAs</article-title><source>Cells</source><year>2022</year><volume>11</volume><fpage>2697</fpage><pub-id pub-id-type="pmid">36078109</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_006"><label>6</label><element-citation publication-type="journal"><name><surname>Ali</surname><given-names>MK</given-names></name><name><surname>Pearson-Stuttard</surname><given-names>J</given-names></name><name><surname>Selvin</surname><given-names>E</given-names></name><name><surname>Gregg</surname><given-names>EW</given-names></name><article-title>Interpreting global trends in type 2 diabetes complications and mortality</article-title><source>Diabetologia</source><year>2022</year><volume>65</volume><fpage>3</fpage><comment>&#x02013;</comment><lpage>13</lpage><pub-id pub-id-type="pmid">34837505</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_007"><label>7</label><element-citation publication-type="journal"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Pan</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>J</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Inhibition of PHLPP1 ameliorates cardiac dysfunction via activation of the PI3K/Akt/mTOR signalling pathway in diabetic cardiomyopathy</article-title><source>J Cell Mol Med</source><year>2020</year><volume>24</volume><fpage>4612</fpage><comment>&#x02013;</comment><lpage>4623</lpage><pub-id pub-id-type="pmid">32150791</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_008"><label>8</label><element-citation publication-type="journal"><name><surname>Rohm</surname><given-names>TV</given-names></name><name><surname>Meier</surname><given-names>DT</given-names></name><name><surname>Olefsky</surname><given-names>JM</given-names></name><name><surname>Donath</surname><given-names>MY</given-names></name><article-title>Inflammation in obesity, diabetes, and related disorders.</article-title><source>Immunity</source><year>2022</year><volume>55</volume><fpage>31</fpage><comment>-</comment><lpage>55</lpage><pub-id pub-id-type="pmid">35021057</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_009"><label>9</label><element-citation publication-type="journal"><name><surname>Magee</surname><given-names>C</given-names></name><name><surname>Grieve</surname><given-names>DJ</given-names></name><name><surname>Watson</surname><given-names>CJ</given-names></name><name><surname>Brazil</surname><given-names>DP</given-names></name><article-title>Diabetic Nephropathy: a Tangled Web to Unweave</article-title><source>Cardiovasc Drugs Ther</source><year>2017</year><volume>31</volume><fpage>579</fpage><comment>-</comment><lpage>592</lpage><pub-id pub-id-type="pmid">28956186</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_010"><label>10</label><element-citation publication-type="journal"><name><surname>Vujosevic</surname><given-names>S</given-names></name><name><surname>Aldington</surname><given-names>SJ</given-names></name><name><surname>Silva</surname><given-names>P</given-names></name><name><surname>Hern&#x000e1;ndez</surname><given-names>C</given-names></name><name><surname>Scanlon</surname><given-names>P</given-names></name><name><surname>Peto</surname><given-names>T</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Screening for diabetic retinopathy: new perspectives and challenges</article-title><source>Lancet Diabetes Endocrinol</source><year>2020</year><volume>8</volume><fpage>337</fpage><comment>&#x02013;</comment><lpage>347</lpage><pub-id pub-id-type="pmid">32113513</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_011"><label>11</label><element-citation publication-type="journal"><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Chandra</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><article-title>Ocular findings, surgery details and outcomes in proliferative diabetic retinopathy patients with chronic kidney disease</article-title><source>PLoS One</source><year>2022</year><volume>17</volume><fpage>e0273133</fpage><pub-id pub-id-type="pmid">36269700</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_012"><label>12</label><element-citation publication-type="journal"><name><surname>Chen</surname><given-names>R</given-names></name><name><surname>Ji</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Cai</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>B</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Glycemic control rate of T2DM outpatients in China: a multi-center survey</article-title><source>Med Sci Monit</source><year>2015</year><volume>21</volume><fpage>1440</fpage><comment>&#x02013;</comment><lpage>1446</lpage><pub-id pub-id-type="pmid">25986070</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_013"><label>13</label><element-citation publication-type="journal"><name><surname>Tily</surname><given-names>H</given-names></name><name><surname>Patridge</surname><given-names>E</given-names></name><name><surname>Cai</surname><given-names>Y</given-names></name><name><surname>Gopu</surname><given-names>V</given-names></name><name><surname>Gline</surname><given-names>S</given-names></name><name><surname>Genkin</surname><given-names>M</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Gut Microbiome Activity Contributes to Prediction of Individual Variation in Glycemic Response in Adults</article-title><source>Diabetes Ther</source><year>2022</year><volume>13</volume><fpage>89</fpage><comment>&#x02013;</comment><lpage>111</lpage><pub-id pub-id-type="pmid">34799839</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_014"><label>14</label><element-citation publication-type="journal"><name><surname>AlHaidar</surname><given-names>AM</given-names></name><name><surname>AlShehri</surname><given-names>NA</given-names></name><name><surname>AlHussaini</surname><given-names>MA</given-names></name><article-title>Family Support and Its Association with Glycemic Control in Adolescents with Type 1 Diabetes Mellitus in Riyadh, Saudi Arabia</article-title><source>J Diabetes Res</source><year>2020</year><volume>2020</volume><fpage>5151604</fpage><pub-id pub-id-type="pmid">32280715</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_015"><label>15</label><element-citation publication-type="journal"><name><surname>Ketema</surname><given-names>EB</given-names></name><name><surname>Kibret</surname><given-names>KT</given-names></name><article-title>Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis</article-title><source>Arch Public Health</source><year>2015</year><volume>73</volume><fpage>43</fpage><pub-id pub-id-type="pmid">26413295</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_016"><label>16</label><element-citation publication-type="journal"><collab>American Diabetes Association. 6</collab><article-title>Glycemic Targets: Standards of Medical Care in Diabetes-2021</article-title><source>Diabetes Care</source><year>2021</year><volume>44</volume><fpage>S73</fpage><comment>-</comment><lpage>S84</lpage><pub-id pub-id-type="pmid">33298417</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_017"><label>17</label><element-citation publication-type="journal"><name><surname>Muller</surname><given-names>PA</given-names></name><name><surname>Matheis</surname><given-names>F</given-names></name><name><surname>Schneeberger</surname><given-names>M</given-names></name><name><surname>Kerner</surname><given-names>Z</given-names></name><name><surname>Jov&#x000e9;</surname><given-names>V</given-names></name><name><surname>Mucida</surname><given-names>D</given-names></name><article-title>Microbiota-modulated CART+ enteric neurons autonomously regulate blood glucose</article-title><source>Science</source><year>2020</year><volume>370</volume><fpage>314</fpage><comment>&#x02013;</comment><lpage>321</lpage><pub-id pub-id-type="pmid">32855216</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_018"><label>18</label><element-citation publication-type="journal"><name><surname>Mart&#x000ed;n-Pel&#x000e1;ez</surname><given-names>S</given-names></name><name><surname>Fito</surname><given-names>M</given-names></name><name><surname>Castaner</surname><given-names>O</given-names></name><article-title>Mediterranean Diet Effects on Type 2 Diabetes Prevention, Disease Progression, and Related Mechanisms. A Review</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><fpage>2236</fpage><pub-id pub-id-type="pmid">32726990</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_019"><label>19</label><element-citation publication-type="journal"><name><surname>Ben&#x000ed;tez-P&#x000e1;ez</surname><given-names>A</given-names></name><name><surname>G&#x000f3;mez Del Pugar</surname><given-names>EM</given-names></name><name><surname>L&#x000f3;pez-Almela</surname><given-names>I</given-names></name><name><surname>Moya-P&#x000e9;rez</surname><given-names>&#x000c1;</given-names></name><name><surname>Codo&#x000f1;er-Franch</surname><given-names>P</given-names></name><name><surname>Sanz</surname><given-names>Y</given-names></name><article-title>Depletion of Blautia Species in the Microbiota of Obese Children Relates to Intestinal Inflammation and Metabolic Phenotype Worsening</article-title><source>mSystems</source><year>2020</year><volume>5</volume><fpage>e00857</fpage><comment>&#x02013;</comment><lpage>00819</lpage><pub-id pub-id-type="pmid">32209719</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_020"><label>20</label><element-citation publication-type="journal"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>ZH</given-names></name><name><surname>Zabed</surname><given-names>HM</given-names></name><name><surname>Yun</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name><article-title>An Insight into the Roles of Dietary Tryptophan and Its Metabolites in Intestinal Inflammation and Inflammatory Bowel Disease</article-title><source>Mol Nutr Food Res</source><year>2021</year><volume>65</volume><fpage>e2000461</fpage><pub-id pub-id-type="pmid">33216452</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_021"><label>21</label><element-citation publication-type="journal"><name><surname>Hyland</surname><given-names>NP</given-names></name><name><surname>Cavanaugh</surname><given-names>CR</given-names></name><name><surname>Hornby</surname><given-names>PJ</given-names></name><article-title>Emerging effects of tryptophan pathway metabolites and intestinal microbiota on metabolism and intestinal function</article-title><source>Amino Acids</source><year>2022</year><volume>54</volume><fpage>57</fpage><comment>&#x02013;</comment><lpage>70</lpage><pub-id pub-id-type="pmid">35038025</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_022"><label>22</label><element-citation publication-type="journal"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>C</given-names></name><article-title>More than 9,000,000 unique genes in human gut bacterial community: estimating gene numbers inside a human body</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><fpage>e6074</fpage><pub-id pub-id-type="pmid">19562079</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_023"><label>23</label><element-citation publication-type="journal"><name><surname>Martin</surname><given-names>AM</given-names></name><name><surname>Sun</surname><given-names>EW</given-names></name><name><surname>Rogers</surname><given-names>GB</given-names></name><name><surname>Keating</surname><given-names>DJ</given-names></name><article-title>The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release</article-title><source>Front Physiol</source><year>2019</year><volume>10</volume><fpage>428</fpage><pub-id pub-id-type="pmid">31057420</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_024"><label>24</label><element-citation publication-type="journal"><name><surname>Stott</surname><given-names>KJ</given-names></name><name><surname>Phillips</surname><given-names>B</given-names></name><name><surname>Parry</surname><given-names>L</given-names></name><name><surname>May</surname><given-names>S</given-names></name><article-title>Recent advancements in the exploitation of the gut microbiome in the diagnosis and treatment of colorectal cancer</article-title><source>Biosci Rep</source><year>2021</year><volume>41</volume><fpage>BSR20204113</fpage><pub-id pub-id-type="pmid">34236075</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_025"><label>25</label><element-citation publication-type="journal"><name><surname>Dominguez-Bello</surname><given-names>MG</given-names></name><name><surname>Godoy-Vitorino</surname><given-names>F</given-names></name><name><surname>Knight</surname><given-names>R</given-names></name><name><surname>Blaser</surname><given-names>MJ</given-names></name><article-title>Role of the microbiome in human development</article-title><source>Gut</source><year>2019</year><volume>68</volume><fpage>1108</fpage><comment>&#x02013;</comment><lpage>1114</lpage><pub-id pub-id-type="pmid">30670574</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_026"><label>26</label><element-citation publication-type="journal"><name><surname>Sikalidis</surname><given-names>AK</given-names></name><name><surname>Maykish</surname><given-names>A</given-names></name><article-title>The Gut Microbiome and Type 2 Diabetes Mellitus: Discussing a Complex Relationship</article-title><source>Biomedicines</source><year>2020</year><volume>8</volume><fpage>8</fpage><pub-id pub-id-type="pmid">31936158</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_027"><label>27</label><element-citation publication-type="journal"><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Brown</surname><given-names>MA</given-names></name><name><surname>Qiao</surname><given-names>S</given-names></name><article-title>Dietary Protein and Gut Microbiota Composition and Function.</article-title><source>Curr Protein Pept Sci</source><year>2019</year><volume>20</volume><fpage>145</fpage><comment>&#x02013;</comment><lpage>154</lpage><pub-id pub-id-type="pmid">29756574</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_028"><label>28</label><element-citation publication-type="journal"><name><surname>Cani</surname><given-names>PD</given-names></name><article-title>Microbiota and metabolites in metabolic diseases</article-title><source>Nat Rev Endocrinol</source><year>2019</year><volume>15</volume><fpage>69</fpage><comment>&#x02013;</comment><lpage>70</lpage><pub-id pub-id-type="pmid">30602737</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_029"><label>29</label><element-citation publication-type="journal"><name><surname>Woerle</surname><given-names>HJ</given-names></name><name><surname>Neumann</surname><given-names>C</given-names></name><name><surname>Zschau</surname><given-names>S</given-names></name><name><surname>Tenner</surname><given-names>S</given-names></name><name><surname>Irsigler</surname><given-names>A</given-names></name><name><surname>Schirra</surname><given-names>J</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes. Importance of postprandial glycemia to achieve target HbA1C levels</article-title><source>Diabetes Res Clin Pract</source><year>2007</year><volume>77</volume><fpage>280</fpage><comment>-</comment><lpage>285</lpage><pub-id pub-id-type="pmid">17240473</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_030"><label>30</label><element-citation publication-type="journal"><name><surname>Monnier</surname><given-names>L</given-names></name><name><surname>Colette</surname><given-names>C</given-names></name><article-title>Contributions of fasting and postprandial glucose to hemoglobin A1c</article-title><source>Endocr Pract</source><year>2006</year><comment>12 Suppl</comment><volume>1</volume><fpage>42</fpage><comment>-</comment><lpage>6</lpage></element-citation></ref><ref id="j_jtim-2023-0116_ref_031"><label>31</label><element-citation publication-type="journal"><name><surname>Deguchi</surname><given-names>S</given-names></name><name><surname>Ogata</surname><given-names>F</given-names></name><name><surname>Isaka</surname><given-names>T</given-names></name><name><surname>Otake</surname><given-names>H</given-names></name><name><surname>Nakazawa</surname><given-names>Y</given-names></name><name><surname>Kawasaki</surname><given-names>N</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Prevention of Postprandial Hyperglycemia by Ophthalmic Nanoparticles Based on Protamine Zinc Insulin in the Rabbit</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><fpage>375</fpage><pub-id pub-id-type="pmid">33809008</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_032"><label>32</label><element-citation publication-type="journal"><name><surname>Takao</surname><given-names>T</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Suka</surname><given-names>M</given-names></name><name><surname>Suzuki</surname><given-names>N</given-names></name><name><surname>Yanagisawa</surname><given-names>H</given-names></name><article-title>Association between postprandial hyperglycemia at clinic visits and all-cause and cancer mortality in patients with type 2 diabetes: A long-term historical cohort study in Japan</article-title><source>Diabetes Res Clin Pract</source><year>2019</year><volume>148</volume><fpage>152</fpage><comment>&#x02013;</comment><lpage>159</lpage><pub-id pub-id-type="pmid">30641172</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_033"><label>33</label><element-citation publication-type="journal"><name><surname>Aryangat</surname><given-names>AV</given-names></name><name><surname>Gerich</surname><given-names>JE</given-names></name><article-title>Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk</article-title><source>Vasc Health Risk Manag</source><year>2010</year><volume>6</volume><fpage>145</fpage><comment>&#x02013;</comment><lpage>155</lpage><pub-id pub-id-type="pmid">20448799</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_034"><label>34</label><element-citation publication-type="journal"><name><surname>Raz</surname><given-names>I</given-names></name><name><surname>Ceriello</surname><given-names>A</given-names></name><name><surname>Wilson</surname><given-names>PW</given-names></name><name><surname>Battioui</surname><given-names>C</given-names></name><name><surname>Su</surname><given-names>EW</given-names></name><name><surname>Kerr</surname><given-names>L</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Post hoc subgroup analysis of the HEART2D trial demonstrates lower cardiovascular risk in older patients targeting postprandial versus fasting/premeal glycemia</article-title><source>Diabetes Care</source><year>2011</year><volume>34</volume><fpage>1511</fpage><comment>&#x02013;</comment><lpage>1513</lpage><pub-id pub-id-type="pmid">21593301</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_035"><label>35</label><element-citation publication-type="journal"><name><surname>Hassanein</surname><given-names>M</given-names></name><name><surname>Akbar</surname><given-names>MAJ</given-names></name><name><surname>Al-Shamiri</surname><given-names>M</given-names></name><name><surname>Amir</surname><given-names>A</given-names></name><name><surname>Amod</surname><given-names>A</given-names></name><name><surname>Chudleigh</surname><given-names>R</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Management of Diabetes and Hypertension within the Gulf Region: Updates on Treatment Practices and Therapies</article-title><source>Diabetes Ther</source><year>2022</year><volume>13</volume><fpage>1253</fpage><comment>&#x02013;</comment><lpage>1280</lpage><pub-id pub-id-type="pmid">35679010</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_036"><label>36</label><element-citation publication-type="journal"><name><surname>Jin</surname><given-names>X</given-names></name><name><surname>Lin</surname><given-names>S</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>EH</given-names></name><name><surname>Morgenstern</surname><given-names>MP</given-names></name><name><surname>Wilson</surname><given-names>AJ</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Ethnicity impact on oral processing behaviour and glycemic response to noodles: Chinese (Asian) vs. New Zealander (Caucasian)</article-title><source>Food Funct</source><year>2022</year><volume>13</volume><fpage>3840</fpage><comment>&#x02013;</comment><lpage>3852</lpage><pub-id pub-id-type="pmid">35315467</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_037"><label>37</label><element-citation publication-type="journal"><name><surname>Ketel</surname><given-names>EC</given-names></name><name><surname>de Wijk</surname><given-names>RA</given-names></name><name><surname>de Graaf</surname><given-names>C</given-names></name><name><surname>Stieger</surname><given-names>M</given-names></name><article-title>Relating oral physiology and anatomy of consumers varying in age, gender and ethnicity to food oral processing behavior</article-title><source>Physiol Behav</source><year>2020</year><volume>215</volume><fpage>112766</fpage><pub-id pub-id-type="pmid">31812520</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_038"><label>38</label><element-citation publication-type="journal"><name><surname>Gribble</surname><given-names>FM</given-names></name><name><surname>Reimann</surname><given-names>F</given-names></name><article-title>Function and mechanisms of enteroendocrine cells and gut hormones in metabolism</article-title><source>Nat Rev Endocrinol</source><year>2019</year><volume>15</volume><fpage>226</fpage><comment>&#x02013;</comment><lpage>237</lpage><pub-id pub-id-type="pmid">30760847</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_039"><label>39</label><element-citation publication-type="journal"><name><surname>Br&#x000f8;nden</surname><given-names>A</given-names></name><name><surname>Knop</surname><given-names>FK</given-names></name><article-title>Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology</article-title><source>J Clin Endocrinol Metab</source><year>2020</year><volume>105</volume><fpage>dgz025</fpage><pub-id pub-id-type="pmid">31630179</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_040"><label>40</label><element-citation publication-type="journal"><name><surname>Reunanen</surname><given-names>J</given-names></name><name><surname>Kainulainen</surname><given-names>V</given-names></name><name><surname>Huuskonen</surname><given-names>L</given-names></name><name><surname>Ottman</surname><given-names>N</given-names></name><name><surname>Belzer</surname><given-names>C</given-names></name><name><surname>Huhtinen</surname><given-names>H</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer</article-title><source>Appl Environ Microbiol</source><year>2015</year><volume>81</volume><fpage>3655</fpage><comment>&#x02013;</comment><lpage>3662</lpage><pub-id pub-id-type="pmid">25795669</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_041"><label>41</label><element-citation publication-type="journal"><name><surname>Plovier</surname><given-names>H</given-names></name><name><surname>Everard</surname><given-names>A</given-names></name><name><surname>Druart</surname><given-names>C</given-names></name><name><surname>Depommier</surname><given-names>C</given-names></name><name><surname>Van</surname><given-names>Hul M</given-names></name><name><surname>Geurts</surname><given-names>L</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice</article-title><source>Nat Med</source><year>2017</year><volume>23</volume><fpage>107</fpage><comment>&#x02013;</comment><lpage>113</lpage><pub-id pub-id-type="pmid">27892954</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_042"><label>42</label><element-citation publication-type="journal"><name><surname>Pustozerov</surname><given-names>E</given-names></name><name><surname>Tkachuk</surname><given-names>A</given-names></name><name><surname>Vasukova</surname><given-names>E</given-names></name><name><surname>Dronova</surname><given-names>A</given-names></name><name><surname>Shilova</surname><given-names>E</given-names></name><name><surname>Anopova</surname><given-names>A</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>The Role of Glycemic Index and Glycemic Load in the Development of Real-Time Postprandial Glycemic Response Prediction Models for Patients With Gestational Diabetes</article-title><source>Nutrients</source><year>2020</year><volume>12</volume><fpage>302</fpage><pub-id pub-id-type="pmid">31979294</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_043"><label>43</label><element-citation publication-type="journal"><name><surname>Rein</surname><given-names>M</given-names></name><name><surname>Ben-Yacov</surname><given-names>O</given-names></name><name><surname>Godneva</surname><given-names>A</given-names></name><name><surname>Shilo</surname><given-names>S</given-names></name><name><surname>Zmora</surname><given-names>N</given-names></name><name><surname>Kolobkov</surname><given-names>D</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial</article-title><source>BMC Med</source><year>2022</year><volume>20</volume><fpage>56</fpage><pub-id pub-id-type="pmid">35135549</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_044"><label>44</label><element-citation publication-type="journal"><name><surname>Attaye</surname><given-names>I</given-names></name><name><surname>Pinto-Sietsma</surname><given-names>SJ</given-names></name><name><surname>Herrema</surname><given-names>H</given-names></name><name><surname>Nieuwdorp</surname><given-names>M</given-names></name><article-title>A Crucial Role for Diet in the Relationship Between Gut Microbiota and Cardiometabolic Disease</article-title><source>Annu Rev Med</source><year>2020</year><volume>71</volume><fpage>149</fpage><comment>&#x02013;</comment><lpage>161</lpage><pub-id pub-id-type="pmid">31479620</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_045"><label>45</label><element-citation publication-type="journal"><name><surname>Zeevi</surname><given-names>D</given-names></name><name><surname>Korem</surname><given-names>T</given-names></name><name><surname>Zmora</surname><given-names>N</given-names></name><name><surname>Israeli</surname><given-names>D</given-names></name><name><surname>Rothschild</surname><given-names>D</given-names></name><name><surname>Weinberger</surname><given-names>A</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Personalized Nutrition by Prediction of Glycemic Responses</article-title><source>Cell</source><year>2015</year><volume>163</volume><fpage>1079</fpage><comment>&#x02013;</comment><lpage>1094</lpage><pub-id pub-id-type="pmid">26590418</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_046"><label>46</label><element-citation publication-type="journal"><name><surname>S&#x000f8;ndertoft</surname><given-names>NB</given-names></name><name><surname>Vogt</surname><given-names>JK</given-names></name><name><surname>Arumugam</surname><given-names>M</given-names></name><name><surname>Kristensen</surname><given-names>M</given-names></name><name><surname>G&#x000f8;bel</surname><given-names>RJ</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>The intestinal microbiome is a co-determinant of the postprandial plasma glucose response</article-title><source>PLoS One</source><year>2020</year><volume>15</volume><fpage>e0238648</fpage><pub-id pub-id-type="pmid">32947608</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_047"><label>47</label><element-citation publication-type="journal"><name><surname>Nolte</surname><given-names>Fong JV</given-names></name><name><surname>Miketinas</surname><given-names>D</given-names></name><name><surname>Moore</surname><given-names>LW</given-names></name><name><surname>Nguyen</surname><given-names>DT</given-names></name><name><surname>Graviss</surname><given-names>EA</given-names></name><name><surname>Ajami</surname><given-names>N</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Precision Nutrition Model Predicts Glucose Control of Overweight Females Following the Consumption of Potatoes High in Resistant Starch</article-title><source>Nutrients</source><year>2022</year><volume>14</volume><fpage>268</fpage><pub-id pub-id-type="pmid">35057449</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_048"><label>48</label><element-citation publication-type="journal"><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Sun</surname><given-names>TY</given-names></name><name><surname>He</surname><given-names>Y</given-names></name><name><surname>Gou</surname><given-names>W</given-names></name><name><surname>Zuo</surname><given-names>LS</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Dietary fruit and vegetable intake, gut microbiota, and type 2 diabetes: results from two large human cohort studies</article-title><source>BMC Med</source><year>2020</year><volume>18</volume><fpage>371</fpage><pub-id pub-id-type="pmid">33267887</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_049"><label>49</label><element-citation publication-type="journal"><name><surname>Mineshita</surname><given-names>Y</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Shibata</surname><given-names>S</given-names></name><article-title>Relationship between Fasting and Postprandial Glucose Levels and the Gut Microbiota</article-title><source>Metabolites</source><year>2022</year><volume>12</volume><fpage>669</fpage><pub-id pub-id-type="pmid">35888793</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_050"><label>50</label><element-citation publication-type="journal"><name><surname>He Xue</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name><name><surname>Lv</surname><given-names>XG</given-names></name><name><surname>Yi</surname><given-names>J</given-names></name><article-title>Systematic evaluation of intestinal flora characteristics and their correlation in patients with diabetes</article-title><source>Zhongguo Weishengtaixue Zazhi</source><year>2020</year><volume>32</volume><fpage>397</fpage><comment>-</comment><lpage>403</lpage></element-citation></ref><ref id="j_jtim-2023-0116_ref_051"><label>51</label><element-citation publication-type="journal"><name><surname>Sofi</surname><given-names>MH</given-names></name><name><surname>Johnson</surname><given-names>BM</given-names></name><name><surname>Gudi</surname><given-names>RR</given-names></name><name><surname>Jolly</surname><given-names>A</given-names></name><name><surname>Gaudreau</surname><given-names>MC</given-names></name><name><surname>Vasu</surname><given-names>C</given-names></name><article-title>Polysaccharide A-Dependent Opposing Effects of Mucosal and Systemic Exposures to Human Gut Commensal Bacteroides fragilis in Type 1 Diabetes</article-title><source>Diabetes</source><year>2019</year><volume>68</volume><fpage>1975</fpage><comment>&#x02013;</comment><lpage>1989</lpage><pub-id pub-id-type="pmid">31311801</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_052"><label>52</label><element-citation publication-type="journal"><name><surname>Leiva-Gea</surname><given-names>I</given-names></name><name><surname>S&#x000e1;nchez-Alcoholado</surname><given-names>L</given-names></name><name><surname>Mart&#x000ed;n-Tejedor</surname><given-names>B</given-names></name><name><surname>Castellano-Castillo</surname><given-names>D</given-names></name><name><surname>Moreno-Indias</surname><given-names>I</given-names></name><name><surname>Urda-Cardona</surname><given-names>A</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Gut Microbiota Differs in Composition and Functionality Between Children With Type 1 Diabetes and MODY2 and Healthy Control Subjects: A Case-Control Study</article-title><source>Diabetes Care</source><year>2018</year><volume>41</volume><fpage>2385</fpage><comment>&#x02013;</comment><lpage>2395</lpage><pub-id pub-id-type="pmid">30224347</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_053"><label>53</label><element-citation publication-type="journal"><name><surname>Vitale</surname><given-names>M</given-names></name><name><surname>Giacco</surname><given-names>R</given-names></name><name><surname>Laiola</surname><given-names>M</given-names></name><name><surname>Della</surname><given-names>Pepa G</given-names></name><name><surname>Luongo</surname><given-names>D</given-names></name><name><surname>Mangione</surname><given-names>A</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Acute and chronic improvement in postprandial glucose metabolism by a diet resembling the traditional Mediterranean dietary pattern: Can SCFAs play a role?</article-title><source>Clin Nutr</source><year>2021</year><volume>40</volume><fpage>428</fpage><comment>&#x02013;</comment><lpage>437</lpage><pub-id pub-id-type="pmid">32698959</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_054"><label>54</label><element-citation publication-type="journal"><name><surname>Kim</surname><given-names>JS</given-names></name><name><surname>Nam</surname><given-names>K</given-names></name><name><surname>Chung</surname><given-names>SJ</given-names></name><article-title>Effect of nutrient composition in a mixed meal on the postprandial glycemic response in healthy people: a preliminary study</article-title><source>Nutr Res Pract</source><year>2019</year><volume>13</volume><fpage>126</fpage><comment>&#x02013;</comment><lpage>133</lpage><pub-id pub-id-type="pmid">30984356</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_055"><label>55</label><element-citation publication-type="journal"><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Matthan</surname><given-names>NR</given-names></name><name><surname>Ausman</surname><given-names>LM</given-names></name><name><surname>Lichtenstein</surname><given-names>AH</given-names></name><article-title>Effect of macronutrients and fiber on postprandial glycemic responses and meal glycemic index and glycemic load value determinations</article-title><source>Am J Clin Nutr</source><year>2017</year><volume>105</volume><fpage>842</fpage><comment>&#x02013;</comment><lpage>853</lpage><pub-id pub-id-type="pmid">28202475</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_056"><label>56</label><element-citation publication-type="journal"><name><surname>Shilo</surname><given-names>S</given-names></name><name><surname>Godneva</surname><given-names>A</given-names></name><name><surname>Rachmiel</surname><given-names>M</given-names></name><name><surname>Korem</surname><given-names>T</given-names></name><name><surname>Kolobkov</surname><given-names>D</given-names></name><name><surname>Karady</surname><given-names>T</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Prediction of Personal Glycemic Responses to Food for Individuals With Type 1 Diabetes Through Integration of Clinical and Microbial Data</article-title><source>Diabetes Care</source><year>2022</year><volume>45</volume><fpage>502</fpage><comment>&#x02013;</comment><lpage>511</lpage><pub-id pub-id-type="pmid">34711639</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_057"><label>57</label><element-citation publication-type="journal"><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Cai</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>A metagenome-wide association study of gut microbiota in type 2 diabetes</article-title><source>Nature</source><year>2012</year><volume>490</volume><fpage>55</fpage><comment>&#x02013;</comment><lpage>60</lpage><pub-id pub-id-type="pmid">23023125</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_058"><label>58</label><element-citation publication-type="journal"><name><surname>Canfora</surname><given-names>EE</given-names></name><name><surname>Meex</surname><given-names>RCR</given-names></name><name><surname>Venema</surname><given-names>K</given-names></name><name><surname>Blaak</surname><given-names>EE</given-names></name><article-title>Gut microbial metabolites in obesity, NAFLD and T2DM</article-title><source>Nat Rev Endocrinol</source><year>2019</year><volume>15</volume><fpage>261</fpage><comment>&#x02013;</comment><lpage>273</lpage><pub-id pub-id-type="pmid">30670819</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_059"><label>59</label><element-citation publication-type="journal"><name><surname>Xu</surname><given-names>HB</given-names></name><article-title>Analysis of intestinal flora characteristics and blood glucose control level in 315 elderly patients with type 2 diabetes</article-title><source>Chin J Physician</source><year>2017</year><volume>19</volume><fpage>130</fpage><comment>-</comment><lpage>132</lpage></element-citation></ref><ref id="j_jtim-2023-0116_ref_060"><label>60</label><element-citation publication-type="journal"><name><surname>Feng</surname><given-names>G</given-names></name><name><surname>Zhong</surname><given-names>WZ</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>XL</given-names></name><article-title>Effects of probiotics on constant natural killer T cells, blood glucose indicators, inflammatory factors and intestinal flora in patients with type 2 diabetes</article-title><source>Zhongguo Yaoye</source><year>2022</year><volume>31</volume><fpage>50</fpage><comment>-</comment><lpage>54</lpage></element-citation></ref><ref id="j_jtim-2023-0116_ref_061"><label>61</label><element-citation publication-type="journal"><name><surname>Meyer</surname><given-names>D</given-names></name><article-title>Health benefits of prebiotic fibers</article-title><source>Adv Food Nutr Res</source><year>2015</year><volume>74</volume><fpage>47</fpage><comment>&#x02013;</comment><lpage>91</lpage><pub-id pub-id-type="pmid">25624035</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_062"><label>62</label><element-citation publication-type="journal"><name><surname>Bel&#x000e9;n</surname><given-names>Sanz-Martos A</given-names></name><name><surname>Fern&#x000e1;ndez-Felipe</surname><given-names>J</given-names></name><name><surname>Merino</surname><given-names>B</given-names></name><name><surname>Cano</surname><given-names>V</given-names></name><name><surname>Ruiz-Gayo</surname><given-names>M</given-names></name><name><surname>Del</surname><given-names>Olmo N</given-names></name><article-title>Butyric Acid Precursor Tributyrin Modulates Hippocampal Synaptic Plasticity and Prevents Spatial Memory Deficits: Role of PPAR&#x003b3; and AMPK</article-title><source>Int J Neuropsychopharmacol</source><year>2022</year><volume>25</volume><fpage>498</fpage><comment>&#x02013;</comment><lpage>511</lpage><pub-id pub-id-type="pmid">35152284</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_063"><label>63</label><element-citation publication-type="journal"><name><surname>Roh</surname><given-names>TT</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Rudolph</surname><given-names>S</given-names></name><name><surname>Gee</surname><given-names>M</given-names></name><name><surname>Kaplan</surname><given-names>DL</given-names></name><article-title>InVitro Models of Intestine Innate Immunity</article-title><source>Trends Biotechnol</source><year>2021</year><volume>39</volume><fpage>274</fpage><comment>&#x02013;</comment><lpage>285</lpage><pub-id pub-id-type="pmid">32854949</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_064"><label>64</label><element-citation publication-type="journal"><name><surname>Kwek</surname><given-names>E</given-names></name><name><surname>Yan</surname><given-names>C</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Hao</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>KY</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Effects of Thermally-Oxidized Frying Oils (Corn Oil and Lard) on Gut Microbiota in Hamsters</article-title><source>Antioxidants (Basel)</source><year>2022</year><volume>11</volume><fpage>1732</fpage><pub-id pub-id-type="pmid">36139806</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_065"><label>65</label><element-citation publication-type="journal"><name><surname>Hern&#x000e1;ndez-Maldonado</surname><given-names>LM</given-names></name><name><surname>Blancas-Ben&#x000ed;tez</surname><given-names>FJ</given-names></name><name><surname>Zamora-Gasga</surname><given-names>VM</given-names></name><name><surname>C&#x000e1;rdenas-Castro</surname><given-names>AP</given-names></name><name><surname>Tovar</surname><given-names>J</given-names></name><name><surname>S&#x000e1;yago-Ayerdi</surname><given-names>SG</given-names></name><article-title>In Vitro Gastrointestinal Digestion and Colonic Fermentation of High Dietary Fiber and Antioxidant-Rich Mango (Mangifera indica L.) "Ataulfo"-Based Fruit Bars</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><fpage>1564</fpage><pub-id pub-id-type="pmid">31336740</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_066"><label>66</label><element-citation publication-type="journal"><name><surname>Shang</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Inulin improves the egg production performance and affects the cecum microbiota of laying hens</article-title><source>Int J Biol Macromol</source><year>2020</year><volume>155</volume><fpage>1599</fpage><comment>&#x02013;</comment><lpage>1609</lpage><pub-id pub-id-type="pmid">31751722</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_067"><label>67</label><element-citation publication-type="journal"><name><surname>Ting</surname><given-names>CH</given-names></name><name><surname>Pan</surname><given-names>CY</given-names></name><name><surname>Chen</surname><given-names>YC</given-names></name><name><surname>Lin</surname><given-names>YC</given-names></name><name><surname>Chen</surname><given-names>TY</given-names></name><name><surname>Rajanbabu</surname><given-names>V</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Impact of Tilapia hepcidin 2-3 dietary supplementation on the gut microbiota profile and immunomodulation in the grouper (Epinephelus lanceolatus)</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><fpage>19047</fpage><pub-id pub-id-type="pmid">31836758</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_068"><label>68</label><element-citation publication-type="journal"><name><surname>Szczuko</surname><given-names>M</given-names></name><name><surname>Kikut</surname><given-names>J</given-names></name><name><surname>Maciejewska</surname><given-names>D</given-names></name><name><surname>Kulpa</surname><given-names>D</given-names></name><name><surname>Celewicz</surname><given-names>Z</given-names></name><name><surname>Zi&#x00119;tek</surname><given-names>M</given-names></name><article-title>The Associations of SCFA with Anthropometric Parameters and Carbohydrate Metabolism in Pregnant Women</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><fpage>9212</fpage><pub-id pub-id-type="pmid">33287163</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_069"><label>69</label><element-citation publication-type="journal"><name><surname>Tolhurst</surname><given-names>G</given-names></name><name><surname>Heffron</surname><given-names>H</given-names></name><name><surname>Lam</surname><given-names>YS</given-names></name><name><surname>Parker</surname><given-names>HE</given-names></name><name><surname>Habib</surname><given-names>AM</given-names></name><name><surname>Diakogiannaki</surname><given-names>E</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2</article-title><source>Diabetes</source><year>2012</year><volume>61</volume><fpage>364</fpage><comment>&#x02013;</comment><lpage>371</lpage><pub-id pub-id-type="pmid">22190648</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_070"><label>70</label><element-citation publication-type="journal"><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Ahmed</surname><given-names>K</given-names></name><name><surname>Gille</surname><given-names>A</given-names></name><name><surname>Lu</surname><given-names>S</given-names></name><name><surname>Gr&#x000f6;ne</surname><given-names>HJ</given-names></name><name><surname>Tunaru</surname><given-names>S</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes</article-title><source>Nat Med</source><year>2015</year><volume>21</volume><fpage>173</fpage><comment>&#x02013;</comment><lpage>177</lpage><pub-id pub-id-type="pmid">25581519</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_071"><label>71</label><element-citation publication-type="journal"><name><surname>Shimizu</surname><given-names>H</given-names></name><name><surname>Masujima</surname><given-names>Y</given-names></name><name><surname>Ushiroda</surname><given-names>C</given-names></name><name><surname>Mizushima</surname><given-names>R</given-names></name><name><surname>Taira</surname><given-names>S</given-names></name><name><surname>Ohue-Kitano</surname><given-names>R</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Dietary short-chain fatty acid intake improves the hepatic metabolic condition via FFAR3</article-title><source>Sci Rep</source><year>2019</year><volume>9</volume><fpage>16574</fpage><pub-id pub-id-type="pmid">31719611</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_072"><label>72</label><element-citation publication-type="journal"><name><surname>Louis</surname><given-names>P</given-names></name><name><surname>Young</surname><given-names>P</given-names></name><name><surname>Holtrop</surname><given-names>G</given-names></name><name><surname>Flint</surname><given-names>HJ</given-names></name><article-title>Diversity of human colonic butyrate-producing bacteria revealed by analysis of the butyryl- CoA:acetate CoA-transferase gene</article-title><source>Environ Microbiol</source><year>2010</year><volume>12</volume><fpage>304</fpage><comment>&#x02013;</comment><lpage>314</lpage><pub-id pub-id-type="pmid">19807780</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_073"><label>73</label><element-citation publication-type="journal"><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Fan</surname><given-names>C</given-names></name><name><surname>Liang</surname><given-names>A</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>P</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Effects of SCFA on the DNA methylation pattern of adiponectin and resistin in high-fat-diet-induced obese male mice</article-title><source>Br J Nutr</source><year>2018</year><volume>120</volume><fpage>385</fpage><comment>&#x02013;</comment><lpage>392</lpage><pub-id pub-id-type="pmid">29925443</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_074"><label>74</label><element-citation publication-type="journal"><name><surname>Nishitsuji</surname><given-names>K</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Nagatomo</surname><given-names>R</given-names></name><name><surname>Umemoto</surname><given-names>H</given-names></name><name><surname>Morimoto</surname><given-names>Y</given-names></name><name><surname>Akatsu</surname><given-names>H</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Analysis of the gut microbiome and plasma short-chain fatty acid profiles in a spontaneous mouse model of metabolic syndrome</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>15876</fpage><pub-id pub-id-type="pmid">29158587</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_075"><label>75</label><element-citation publication-type="journal"><name><surname>Larraufie</surname><given-names>P</given-names></name><name><surname>Martin-Gallausiaux</surname><given-names>C</given-names></name><name><surname>Lapaque</surname><given-names>N</given-names></name><name><surname>Dore</surname><given-names>J</given-names></name><name><surname>Gribble</surname><given-names>FM</given-names></name><name><surname>Reimann</surname><given-names>F</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>SCFAs strongly stimulate PYY production in human enteroendocrine cells</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>74</fpage><pub-id pub-id-type="pmid">29311617</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_076"><label>76</label><element-citation publication-type="journal"><name><surname>Ye</surname><given-names>P</given-names></name><name><surname>Xi</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>P</given-names></name><article-title>Linking Obesity with Colorectal Cancer: Epidemiology and Mechanistic Insights</article-title><source>Cancers (Basel)</source><year>2020</year><volume>12</volume><fpage>1408</fpage><pub-id pub-id-type="pmid">32486076</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_077"><label>77</label><element-citation publication-type="journal"><name><surname>Proungvitaya</surname><given-names>S</given-names></name><name><surname>Sombattheera</surname><given-names>S</given-names></name><name><surname>Boonsiri</surname><given-names>P</given-names></name><name><surname>Limpaiboon</surname><given-names>T</given-names></name><name><surname>Wongkham</surname><given-names>S</given-names></name><name><surname>Wongkham</surname><given-names>C</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Diagnostic value of serum bile acid composition patterns and serum glycocholic acid levels in cholangiocarcinoma</article-title><source>Oncol Lett</source><year>2017</year><volume>14</volume><fpage>4943</fpage><comment>&#x02013;</comment><lpage>4948</lpage><pub-id pub-id-type="pmid">29085505</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_078"><label>78</label><element-citation publication-type="journal"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><article-title>Correlations of Fecal Metabonomic and Microbiomic Changes Induced by High-fat Diet in the Pre-Obesity State</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>21618</fpage><pub-id pub-id-type="pmid">26916743</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_079"><label>79</label><element-citation publication-type="journal"><name><surname>Li</surname><given-names>M</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Pang</surname><given-names>S</given-names></name><article-title>A Possible Mechanism of Metformin in Improving Insulin Resistance in Diabetic Rat Models</article-title><source>Int J Endocrinol</source><year>2019</year><volume>2019</volume><fpage>3248527</fpage><pub-id pub-id-type="pmid">31737069</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_080"><label>80</label><element-citation publication-type="journal"><name><surname>Thomas</surname><given-names>C</given-names></name><name><surname>Pellicciari</surname><given-names>R</given-names></name><name><surname>Pruzanski</surname><given-names>M</given-names></name><name><surname>Auwerx</surname><given-names>J</given-names></name><name><surname>Schoonjans</surname><given-names>K</given-names></name><article-title>Targeting bile-acid signalling for metabolic diseases</article-title><source>Nat Rev Drug Discov</source><year>2008</year><volume>7</volume><fpage>678</fpage><comment>&#x02013;</comment><lpage>693</lpage><pub-id pub-id-type="pmid">18670431</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_081"><label>81</label><element-citation publication-type="journal"><name><surname>Kiriyama</surname><given-names>Y</given-names></name><name><surname>Nochi</surname><given-names>H</given-names></name><article-title>The Biosynthesis, Signaling, and Neurological Functions of Bile Acids</article-title><source>Biomolecules</source><year>2019</year><volume>9</volume><fpage>232</fpage><pub-id pub-id-type="pmid">31208099</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_082"><label>82</label><element-citation publication-type="journal"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Choi</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Kim</surname><given-names>EY</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><name><surname>Saha</surname><given-names>PK</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice</article-title><source>Hepatology</source><year>2017</year><volume>66</volume><fpage>498</fpage><comment>&#x02013;</comment><lpage>509</lpage><pub-id pub-id-type="pmid">28378930</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_083"><label>83</label><element-citation publication-type="journal"><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Pathak</surname><given-names>P</given-names></name><name><surname>Boehme</surname><given-names>S</given-names></name><name><surname>Chiang</surname><given-names>JL</given-names></name><article-title>Cholesterol 7&#x003b1;-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis</article-title><source>J Lipid Res</source><year>2016</year><volume>57</volume><fpage>1831</fpage><comment>&#x02013;</comment><lpage>1844</lpage><pub-id pub-id-type="pmid">27534992</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_084"><label>84</label><element-citation publication-type="journal"><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Owsley</surname><given-names>E</given-names></name><name><surname>Matozel</surname><given-names>M</given-names></name><name><surname>Hsu</surname><given-names>P</given-names></name><name><surname>Novak</surname><given-names>CM</given-names></name><name><surname>Chiang</surname><given-names>JY</given-names></name><article-title>Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice</article-title><source>Hepatology</source><year>2010</year><volume>52</volume><fpage>678</fpage><comment>&#x02013;</comment><lpage>690</lpage><pub-id pub-id-type="pmid">20623580</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_085"><label>85</label><element-citation publication-type="journal"><name><surname>Katsuma</surname><given-names>S</given-names></name><name><surname>Hirasawa</surname><given-names>A</given-names></name><name><surname>Tsujimoto</surname><given-names>G</given-names></name><article-title>Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1</article-title><source>Biochem Biophys Res Commun</source><year>2005</year><volume>329</volume><fpage>386</fpage><comment>&#x02013;</comment><lpage>390</lpage><pub-id pub-id-type="pmid">15721318</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_086"><label>86</label><element-citation publication-type="journal"><name><surname>Shapiro</surname><given-names>H</given-names></name><name><surname>Kolodziejczyk</surname><given-names>AA</given-names></name><name><surname>Halstuch</surname><given-names>D</given-names></name><name><surname>Elinav</surname><given-names>E</given-names></name><article-title>Bile acids in glucose metabolism in health and disease</article-title><source>J Exp Med</source><year>2018</year><volume>215</volume><fpage>383</fpage><comment>&#x02013;</comment><lpage>396</lpage><pub-id pub-id-type="pmid">29339445</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_087"><label>87</label><element-citation publication-type="journal"><name><surname>Schittenhelm</surname><given-names>B</given-names></name><name><surname>Wagner</surname><given-names>R</given-names></name><name><surname>K&#x000e4;hny</surname><given-names>V</given-names></name><name><surname>Peter</surname><given-names>A</given-names></name><name><surname>Krippeit-Drews</surname><given-names>P</given-names></name><name><surname>D&#x000fc;fer</surname><given-names>M</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Role of FXR in &#x003b2;-cells of lean and obese mice</article-title><source>Endocrinology</source><year>2015</year><volume>156</volume><fpage>1263</fpage><comment>&#x02013;</comment><lpage>1271</lpage><pub-id pub-id-type="pmid">25599407</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_088"><label>88</label><element-citation publication-type="journal"><name><surname>Kumar</surname><given-names>DP</given-names></name><name><surname>Asgharpour</surname><given-names>A</given-names></name><name><surname>Mirshahi</surname><given-names>F</given-names></name><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Imai</surname><given-names>Y</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet &#x003b1; Cells to Promote Glucose Homeostasis</article-title><source>J Biol Chem</source><year>2016</year><volume>291</volume><fpage>6626</fpage><comment>&#x02013;</comment><lpage>6640</lpage><pub-id pub-id-type="pmid">26757816</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_089"><label>89</label><element-citation publication-type="journal"><name><surname>Hansen</surname><given-names>M</given-names></name><name><surname>Sonne</surname><given-names>DP</given-names></name><name><surname>Mikkelsen</surname><given-names>KH</given-names></name><name><surname>Gluud</surname><given-names>LL</given-names></name><name><surname>Vilsb&#x000f8;ll</surname><given-names>T</given-names></name><name><surname>Knop</surname><given-names>FK</given-names></name><article-title>Bile acid sequestrants for glycemic control in patients with type 2 diabetes: A systematic review with meta-analysis of randomized controlled trials</article-title><source>J Diabetes Complications</source><year>2017</year><volume>31</volume><fpage>918</fpage><comment>&#x02013;</comment><lpage>927</lpage><pub-id pub-id-type="pmid">28238556</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_090"><label>90</label><element-citation publication-type="journal"><name><surname>Bozadjieva</surname><given-names>N</given-names></name><name><surname>Heppner</surname><given-names>KM</given-names></name><name><surname>Seeley</surname><given-names>RJ</given-names></name><article-title>Targeting FXR and FGF 19 to Treat Metabolic Diseases-Lessons Learned From Bariatric Surgery</article-title><source>Diabetes</source><year>2018</year><volume>67</volume><fpage>1720</fpage><comment>&#x02013;</comment><lpage>1728</lpage><pub-id pub-id-type="pmid">30135133</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_091"><label>91</label><element-citation publication-type="journal"><name><surname>So</surname><given-names>SSY</given-names></name><name><surname>Yeung</surname><given-names>CHC</given-names></name><name><surname>Schooling</surname><given-names>CM</given-names></name><name><surname>El-Nezami</surname><given-names>H</given-names></name><article-title>Targeting bile acid metabolism in obesity reduction: A systematic review and meta-analysis</article-title><source>Obes Rev</source><year>2020</year><volume>21</volume><fpage>e13017</fpage><pub-id pub-id-type="pmid">32187830</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_092"><label>92</label><element-citation publication-type="journal"><name><surname>Kaska</surname><given-names>L</given-names></name><name><surname>Sledzinski</surname><given-names>T</given-names></name><name><surname>Chomiczewska</surname><given-names>A</given-names></name><name><surname>Dettlaff-Pokora</surname><given-names>A</given-names></name><name><surname>Swierczynski</surname><given-names>J</given-names></name><article-title>Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome</article-title><source>World J Gastroenterol</source><year>2016</year><volume>22</volume><fpage>8698</fpage><comment>&#x02013;</comment><lpage>8719</lpage><pub-id pub-id-type="pmid">27818587</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_093"><label>93</label><element-citation publication-type="journal"><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><article-title>Indole as an intercellular signal in microbial communities</article-title><source>FEMS Microbiol Rev</source><year>2010</year><volume>34</volume><fpage>426</fpage><comment>&#x02013;</comment><lpage>444</lpage><pub-id pub-id-type="pmid">20070374</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_094"><label>94</label><element-citation publication-type="journal"><name><surname>Wyatt</surname><given-names>M</given-names></name><name><surname>Greathouse</surname><given-names>KL</given-names></name><article-title>Targeting Dietary and Microbial Tryptophan-Indole Metabolism as Therapeutic Approaches to Colon Cancer</article-title><source>Nutrients</source><year>2021</year><volume>13</volume><fpage>1189</fpage><pub-id pub-id-type="pmid">33916690</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_095"><label>95</label><element-citation publication-type="journal"><name><surname>Abildgaard</surname><given-names>A</given-names></name><name><surname>Elfving</surname><given-names>B</given-names></name><name><surname>Hokland</surname><given-names>M</given-names></name><name><surname>Wegener</surname><given-names>G</given-names></name><name><surname>Lund</surname><given-names>S</given-names></name><article-title>The microbial metabolite indole-3-propionic acid improves glucose metabolism in rats, but does not affect behaviour</article-title><source>Arch Physiol Biochem</source><year>2018</year><volume>124</volume><fpage>306</fpage><comment>&#x02013;</comment><lpage>312</lpage><pub-id pub-id-type="pmid">29113509</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_096"><label>96</label><element-citation publication-type="journal"><name><surname>Qi</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Moon</surname><given-names>JY</given-names></name><name><surname>Chai</surname><given-names>JC</given-names></name><name><surname>Merino</surname><given-names>J</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Host and gut microbial tryptophan metabolism and type 2 diabetes: an integrative analysis of host genetics, diet, gut microbiome and circulating metabolites in cohort studies</article-title><source>Gut</source><year>2022</year><volume>71</volume><fpage>1095</fpage><comment>&#x02013;</comment><lpage>1105</lpage><pub-id pub-id-type="pmid">34127525</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_097"><label>97</label><element-citation publication-type="journal"><name><surname>Craciun</surname><given-names>S</given-names></name><name><surname>Balskus</surname><given-names>EP</given-names></name><article-title>Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme</article-title><source>Proc Natl Acad Sci U S A</source><year>2012</year><volume>109</volume><fpage>21307</fpage><comment>&#x02013;</comment><lpage>21312</lpage><pub-id pub-id-type="pmid">23151509</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_098"><label>98</label><element-citation publication-type="journal"><name><surname>Kalnins</surname><given-names>G</given-names></name><name><surname>Kuka</surname><given-names>J</given-names></name><name><surname>Grinberga</surname><given-names>S</given-names></name><name><surname>Makrecka-Kuka</surname><given-names>M</given-names></name><name><surname>Liepinsh</surname><given-names>E</given-names></name><name><surname>Dambrova</surname><given-names>M</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Structure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae</article-title><source>J Biol Chem</source><year>2015</year><volume>290</volume><fpage>21732</fpage><comment>&#x02013;</comment><lpage>21740</lpage><pub-id pub-id-type="pmid">26187464</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_099"><label>99</label><element-citation publication-type="journal"><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Jameson</surname><given-names>E</given-names></name><name><surname>Crosatti</surname><given-names>M</given-names></name><name><surname>Sch&#x000e4;fer</surname><given-names>H</given-names></name><name><surname>Rajakumar</surname><given-names>K</given-names></name><name><surname>Bugg</surname><given-names>TD</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Carnitine metabolism to trimethylamine by an unusual Riesketype oxygenase from human microbiota</article-title><source>Proc Natl Acad Sci U S A</source><year>2014</year><volume>111</volume><fpage>4268</fpage><comment>&#x02013;</comment><lpage>4273</lpage><pub-id pub-id-type="pmid">24591617</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_100"><label>100</label><element-citation publication-type="journal"><name><surname>Koeth</surname><given-names>RA</given-names></name><name><surname>Levison</surname><given-names>BS</given-names></name><name><surname>Culley</surname><given-names>MK</given-names></name><name><surname>Buffa</surname><given-names>JA</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Gregory</surname><given-names>JC</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>&#x003b3;-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO</article-title><source>Cell Metab</source><year>2014</year><volume>20</volume><fpage>799</fpage><comment>&#x02013;</comment><lpage>812</lpage><pub-id pub-id-type="pmid">25440057</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_101"><label>101</label><element-citation publication-type="journal"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Hao</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>H</given-names></name><article-title>Correlations of Fecal Metabonomic and Microbiomic Changes Induced by High-fat Diet in the Pre-Obesity State</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>21618</fpage><pub-id pub-id-type="pmid">26916743</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_102"><label>102</label><element-citation publication-type="journal"><name><surname>Tang</surname><given-names>WH</given-names></name><name><surname>Hazen</surname><given-names>SL</given-names></name><article-title>The contributory role of gut microbiota in cardiovascular disease</article-title><source>J Clin Invest</source><year>2014</year><volume>124</volume><fpage>4204</fpage><comment>&#x02013;</comment><lpage>4211</lpage><pub-id pub-id-type="pmid">25271725</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_103"><label>103</label><element-citation publication-type="journal"><name><surname>Aron-Wisnewsky</surname><given-names>J</given-names></name><name><surname>Cl&#x000e9;ment</surname><given-names>K</given-names></name><article-title>The gut microbiome, diet, and links to cardiometabolic and chronic disorders</article-title><source>Nat Rev Nephrol</source><year>2016</year><volume>12</volume><fpage>169</fpage><comment>&#x02013;</comment><lpage>181</lpage><pub-id pub-id-type="pmid">26616538</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_104"><label>104</label><element-citation publication-type="journal"><name><surname>Warrier</surname><given-names>M</given-names></name><name><surname>Shih</surname><given-names>DM</given-names></name><name><surname>Burrows</surname><given-names>AC</given-names></name><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Gromovsky</surname><given-names>AD</given-names></name><name><surname>Brown</surname><given-names>AL</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance</article-title><source>Cell Rep</source><year>2015</year><volume>10</volume><fpage>326</fpage><comment>&#x02013;</comment><lpage>338</lpage><pub-id pub-id-type="pmid">25600868</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_105"><label>105</label><element-citation publication-type="journal"><name><surname>Miao</surname><given-names>J</given-names></name><name><surname>Ling</surname><given-names>AV</given-names></name><name><surname>Manthena</surname><given-names>PV</given-names></name><name><surname>Gearing</surname><given-names>ME</given-names></name><name><surname>Graham</surname><given-names>MJ</given-names></name><name><surname>Crooke</surname><given-names>RM</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis</article-title><source>Nat Commun</source><year>2015</year><volume>6</volume><fpage>6498</fpage><pub-id pub-id-type="pmid">25849138</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_106"><label>106</label><element-citation publication-type="journal"><name><surname>Schugar</surname><given-names>RC</given-names></name><name><surname>Willard</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Brown</surname><given-names>JM</given-names></name><article-title>Postprandial gut microbiotadriven choline metabolism links dietary cues to adipose tissue dysfunction</article-title><source>Adipocyte</source><year>2018</year><volume>7</volume><fpage>49</fpage><comment>&#x02013;</comment><lpage>56</lpage><pub-id pub-id-type="pmid">29172946</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_107"><label>107</label><element-citation publication-type="journal"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Xue</surname><given-names>C</given-names></name><name><surname>Xue</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><article-title>Dietary trimethylamine N-oxide exacerbates impaired glucose tolerance in mice fed a high fat diet</article-title><source>J Biosci Bioeng</source><year>2014</year><volume>118</volume><fpage>476</fpage><comment>&#x02013;</comment><lpage>481</lpage><pub-id pub-id-type="pmid">24721123</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_108"><label>108</label><element-citation publication-type="journal"><name><surname>Argyridou</surname><given-names>S</given-names></name><name><surname>Davies</surname><given-names>MJ</given-names></name><name><surname>Biddle</surname><given-names>GJH</given-names></name><name><surname>Bernieh</surname><given-names>D</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Dawkins</surname><given-names>NP</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Evaluation of an 8-Week Vegan Diet on Plasma Trimethylamine-N-Oxide and Postchallenge Glucose in Adults with Dysglycemia or Obesity</article-title><source>J Nutr</source><year>2021</year><volume>151</volume><fpage>1844</fpage><comment>&#x02013;</comment><lpage>1853</lpage><pub-id pub-id-type="pmid">33784394</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_109"><label>109</label><element-citation publication-type="journal"><name><surname>Huda</surname><given-names>MN</given-names></name><name><surname>Salvador</surname><given-names>AC</given-names></name><name><surname>Barrington</surname><given-names>WT</given-names></name><name><surname>Gacasan</surname><given-names>CA</given-names></name><name><surname>D'Souza</surname><given-names>EM</given-names></name><name><surname>Deus</surname><given-names>Ramirez L</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Gut microbiota and host genetics modulate the effect of diverse diet patterns on metabolic health</article-title><source>Front Nutr</source><year>2022</year><volume>9</volume><fpage>896348</fpage><pub-id pub-id-type="pmid">36061898</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_110"><label>110</label><element-citation publication-type="journal"><name><surname>Krzymien</surname><given-names>J</given-names></name><name><surname>Ladyzynski</surname><given-names>P</given-names></name><article-title>Insulin in Type 1 and Type 2 Diabetes-Should the Dose of Insulin Before a Meal be Based on Glycemia or Meal Content?</article-title><source>Nutrients</source><year>2019</year><volume>11</volume><fpage>607</fpage><pub-id pub-id-type="pmid">30871141</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_111"><label>111</label><element-citation publication-type="journal"><name><surname>Dedrick</surname><given-names>S</given-names></name><name><surname>Sundaresh</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Brady</surname><given-names>C</given-names></name><name><surname>Yoo</surname><given-names>T</given-names></name><name><surname>Cronin</surname><given-names>C</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis</article-title><source>Front Endocrinol (Lausanne)</source><year>2020</year><volume>11</volume><fpage>78</fpage><pub-id pub-id-type="pmid">32174888</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_112"><label>112</label><element-citation publication-type="journal"><name><surname>Rothschild</surname><given-names>D</given-names></name><name><surname>Weissbrod</surname><given-names>O</given-names></name><name><surname>Barkan</surname><given-names>E</given-names></name><name><surname>Kurilshikov</surname><given-names>A</given-names></name><name><surname>Korem</surname><given-names>T</given-names></name><name><surname>Zeevi</surname><given-names>D</given-names></name><comment>
<italic toggle="yes">et al.</italic>
</comment><article-title>Environment dominates over host genetics in shaping human gut microbiota</article-title><source>Nature</source><year>2018</year><volume>555</volume><fpage>210</fpage><comment>&#x02013;</comment><lpage>215</lpage><pub-id pub-id-type="pmid">29489753</pub-id>
</element-citation></ref><ref id="j_jtim-2023-0116_ref_113"><label>113</label><element-citation publication-type="journal"><name><surname>Kolodziejczyk</surname><given-names>AA</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Elinav</surname><given-names>E</given-names></name><article-title>Diet-microbiota interactions and personalized nutrition</article-title><source>Nat Rev Microbiol</source><year>2019</year><volume>17</volume><fpage>742</fpage><comment>&#x02013;</comment><lpage>753</lpage><pub-id pub-id-type="pmid">31541197</pub-id>
</element-citation></ref></ref-list></back></article>
